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Pseudomonas syringae pv. actinidiae (Psa) is an emerging bacterial pathogen of
kiwifruit, a major primary export of New Zealand. The emergence of Psa in New
Zealand in 2010 caused immense financial grief with the disease a↵ecting fruit yield
and vine health. Psa is also found in other kiwifruit cultivating countries where it has
also negatively impacted the kiwifruit industry, causing considerable financial strain
for growers.
Genetic analysis has provided valuable insight into the origin and evolution of Psa
in New Zealand, including the emergence of resistance to antimicrobials such as cop-
per control compounds. This study provides a detailed comparison of New Zealand
Psa with other Psa varieties, clarifying aspects such as restriction modification sys-
tems. Informed by this analysis, the study describes attempts to insert a CRISPR/
Cas9 genome editing tool into Psa. It is believed that to achieve this, alterations
of the Streptococcus pyogenes derived CRISPR/Cas9 plasmid was required. The
CRISPR/Cas9 system will provide a valuable tool for the analysis of Psa in terms
of the pathogen virulence and resistance to control compounds.
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1. Introduction
1.1 Pseudomonas syringae pv. actinidiae (Psa)
1.1.1 Psa in New Zealand
Pseudomonas syringae pv. actinidiae (Psa) is a destructive bacterial pathogen of
kiwifruit (Everett et al., 2011). Kiwifruit vines infected with Psa will experience a
range of symptoms including the formation of cankers, red and white exudate, and
cane die back, which ultimately results in a substantial loss of fruit yield and vine
death (Everett et al., 2011). More mild symptoms like leaf spotting and flower wilting
can also be observed (Everett et al., 2011). Symptoms of Psa were first discovered
in New Zealand in Te Puke in 2010, with some vines displaying severe disease. The
disease spread to the majority of kiwifruit cultivars in New Zealand, infecting Actinidia
deliciosa ‘Hayward’ and A. chinensis ‘Hort16A’, with the Hort16A cultivar being more
susceptible (Everett et al., 2011). The aggressive strain of Psa that emerged in New
Zealand was identified to be a part of the global Psa pandemic (Chapman et al.,
2012; Mazzaglia et al., 2012; Vanneste et al., 2013; Butler et al., 2013; McCann et
al., 2013). The disease had severe implications for New Zealand as kiwifruit was, and
still is, one of the country’s most profitable primary exports (Vanneste, 2017). The
industry su↵ered an estimated loss of $930 million in loss of exports by 2014 (Birnie
& Livesey, 2014).
As well as being of economic importance, the Psa outbreak has had a negative social
impact, with loss of employment in the kiwifruit industry. It has also resulted in the
undesirable environmental consequence of the increased use of antimicrobials in an
e↵ort to prevent transmission and to control Psa. Copper is the primary compound
for controlling Psa in New Zealand. Although an essential micro-nutrient for growth,
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an excess of copper ions becomes toxic for the micro-organism (Flemming & Trevors,
1989). However, it can also cause phytotoxicity to the plant (Serizawa et al., 1989). A
significant issue with the prolonged use of heavy metals like copper, is its inability to
breakdown leading to accumulation in soil. The soil is home to a plethora of micro-
organisms which have complex interactions with plants, animals and other micro-
organisms. The excess use of copper may cause the disruption of these communities
and decrease diversity (Mackie et al., 2012; Jeyakumar et al., 2014). Moreover, the
immense selective pressure created by the use of copper drives the acquisition of
copper resistance genes, with the emergence of copper resistant Psa already observed
(Poulter et al., 2016; Colombi et al., 2017).
Antibiotic-based control agents, such as kasugamycin and streptomycin, have also
been used to a limited extent to control Psa in New Zealand (Woodcock, 2016).
Like copper, development of pathogen resistance needs to be considered (Serizawa et
al., 1989), with streptomycin resistant Psa already found in New Zealand (Kiwifruit
Vine Health, 2015). Other measures that have been explored are biological controls,
such as yeast and bacteriophages, as well as agents that stimulate plant growth or
hypersensitive responses (Woodcock, 2016).
1.1.2 The pandemic Psa lineage
The global pandemic Psa lineage that reached New Zealand is also found in Europe,
Chile and China. It was first identified in Italy in 2008 (Ferrante & Scortichini, 2009).
It seems probable this particular lineage of Psa is endemic within China (Mazzaglia
et al., 2012; Butler et al., 2013). It is believed that di↵erent Chinese clones gave rise
to outbreak strains in New Zealand, Italy and Chile (Butler et al., 2013). This con-
clusion was drawn through the analysis of single nucleotide polymorphisms (SNPs)
and integrated and conjugative elements (ICE), which were remarkably similar to the
genomic island PPHGI-1 in P.s pv. phaseolicola (Mazzaglia et al., 2012; Butler et
al., 2013). ICE elements are similar to plasmids where they can horizontally transfer
to di↵erent bacteria, however, ICE elements integrate and excise from the main chro-
mosome (Burrus et al., 2002). Butler et al. demonstrated that the Chinese strain M7
harbours an ICE element almost identical to the ICE element in the New Zealand
outbreak strain ICMP 18708. The only di↵erence was an additional IS (insertion
sequence) element in the M7 ICE element. This particular ICE element is defined as
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Pac ICE1. The Chinese strain M228 shares a similar ICE element to the Italian strain
ICMP 18744, subsequently named Pac ICE2. Strains from Chile were described to
have Pac ICE3 and are hypothesised to have a Chinese origin. The Chinese strain
JZZM11 is reported to harbour an ICE element almost identical to Pac ICE3. All
ICE elements analysed were observed to be approximately 100 kb in length (Butler et
al., 2013). The di↵erent strains of the pandemic lineage were grouped as such due to
having a highly similar chromosome (excluding ICE elements) (Butler et al., 2013).
More recently, strains of the pandemic lineage have also been discovered in Japan
and South Korea, with these likely disseminating from New Zealand and/or China
(Koh et al., 2012; Sawada et al., 2015; Kim et al., 2016). The transmission to Korea
appears to have occurred twice; in 2011 and 2014. It is speculated to be caused by
the importation of contaminated kiwifruit seedlings from China and contaminated
kiwifruit pollen from New Zealand and/or China, respectively (Kim et al., 2016).
Pandemic Psa strains are typically highly virulent and aggressive causing a large
amount of damage to infected orchards worldwide (Everett et al., 2011). Non-pandemic
strains of Psa have been isolated in other regions of the world, with di↵ering levels of
virulence observed.
1.1.3 Global Psa phylogeny
In addition to the pandemic lineage of Psa designated as Biovar 3, there are a number
of related biovars (Biovar 1, 2, 5 and 6). Comparison of the Psa genomes from di↵erent
lineages has provided useful insight. The global Psa population has been divided into
lineages/biovars based on the cumulative work of multiple studies. A summary of
this is detailed in Table 1.1. A close relative of Psa is the pathovar P.s pv. theae,
which can be used as an outgroup in phylogenetic analyses (Marcelletti et al., 2011;
Mazzaglia et al., 2012).
Psa was first isolated in Japan in 1984 (Takikawa et al., 1989), spreading to Italy
where it was brought to attention in 1992 (Scortichini, 1994). These early Japanese
and Italian isolates form Biovar 1. This Biovar was observed to be highly virulent
against the green-fleshed Hayward cultivar in Japan but less damaging in Italy, despite
having the same cultivar variety (Ferrante & Scortichini, 2010). This can be attributed
to the di↵erent climates of Italy and Japan (Marcelletti et al., 2011).
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Strains isolated in South Korea later in the 1980s form Biovar 2 (Koh et al., 1994).
Previously these Korean strains were believed to share the same lineage as early
Japanese and Italian strains; indistinguishable through the limited analysis of their
citrate synthase (cts) gene sequence (Vanneste et al., 2011). However, Mazzaglia et
al. investigated several di↵erent PCR fingerprinting methods to further characterise
these strains (Mazzaglia et al., 2011). The study showed that random amplified
polymorphic DNA techniques (RAPD) provided better resolution in separating early
Korean from early Japanese-Italian strains. This was supported by an earlier study
completed by Lee et al. who hypothesised that the Korean and Japanese strains
have di↵erent phylogenetic origins (Lee et al., 2005). Moreover, the use of multilocus
sequence analysis (MLSA) of housekeeping genes possessed enough discriminatory
power to separate early Japanese-Italian strains from early Korean strains (Chapman
et al., 2012). Similar to early Japanese strains, Psa found in Korea were highly
virulent towards the Hayward cultivar (Koh et al., 1994).
Symptoms of disease were first noted in China in Hunan province as early as 1984
(Fang et al., 1990). The disease was later reported in other kiwifruit cultivating
regions such as Sichuan, Anhui and Shaanxi province (Wang et al., 1992; Cheng et
al., 1995; Liang et al., 2000). More recent isolates collected from China have been
shown to belong in the global pandemic lineage, Biovar 3 (Mazzaglia et al., 2012;
Butler et al., 2013). Other global pandemic strains have been found in New Zealand,
Chile, Europe and more recently Japan and Korea (refer to Table 1.1).
Low pathogenic strains found in New Zealand, Australia and France were previously
described as Biovar 4, however, these strains have now been placed in a new pathovar;
P.s pv. actinidifoliorum (Cunty et al., 2015). They have also been referred to in the
past as Psa-LV, with LV standing for low virulence as they only cause mild symptoms,
not reaching beyond leaf spots (Vanneste et al., 2013).
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Table 1.1: A brief summary of previous work characterising the global phylogeny of
Psa
5
Recently, new strains of Psa have been isolated from the yellow-fleshed Hort16A cul-
tivar in a limited region of Saga Prefecture, Japan and placed in Biovar 5 (Sawada
et al., 2014). Even more recently in Japan, another distinct set of strains were found
in Nagano Prefecture, forming Biovar 6 (Sawada et al., 2016). Conversely, Biovar 6
strains were isolated from the Hayward cultivar (Sawada et al., 2016). Biovar 5 and
Biovar 6 are phylogenetically closest to Biovar 2 and Biovar 3, respectively (Fujikawa
& Sawada, 2016). A phylogenetic tree with the current understanding of the global
Psa genetic relationships can be seen in Figure 1.1.
The recent two Biovars found in Japan are reflective of the larger diversity found
there (Ferrante et al., 2015). Rep-PCR fingerprinting revealed heterogeneity among
Japanese strains isolated between 1984 and 2011, whereas the global pandemic strains
(Biovar 3) had very similar patterns within the lineage (Ferrante et al., 2015). This
is congruent with multiple locus variable number of tandem repeats analysis (MLVA)
(Ciarroni et al., 2015) and whole genome sequencing analysis (McCann et al., 2017).
The high diversity found in Japanese Psa compared to the limited diversity of the
6
global pandemic lineage is unsurprising, with more time given for Japanese strains to
evolve and the clonal nature of the global pandemic.
Figure 1.1: Phylogenetic tree and characteristics of the global Psa population.
The phylogenetic tree is constructed from concatenated partial sequences of four
housekeeping genes (gapA, gltA, gyrB and rpoD). To di↵erentiate Biovar 6 from
Biovar 3, seven housekeeping are required (acnB, cts, gapA, gltA, gyrB, pfk, pgi and
rpoD). The bar represents the number of expected changes per site. Bootstrap values
are indicated at each node. N.D. stands for ‘not determined’. Figure from Vanneste,
2017.
China also represents another geographical location containing large genetic variety
in Psa. Ciarroni et al., suggest there are three distinct ‘clonal complexes’ among the
57 Chinese strains analysed (Ciarroni et al., 2015). China is the suspected origin of
the global pandemic, with Biovar 3 strains likely to be endemic within the country
(Mazzaglia et al., 2012; Butler et al., 2013). As Actinidia deliciosa and A. chinensis
are native to China, the co-evolution of host and pathogen may yield the diversity
found there. Other members of the genus Actinidia occur more widely in Asia.
There have been suggestions of diversity found in Korea where the population has
been divided into three distinct ‘clonal complexes’ (Ciarroni et al., 2015). There
have also been indications of several Korean isolates found to be similar to Biovar
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3 Chilean strains and divergent Chinese strains (McCann et al., 2017). This was
concluded through variant calling of whole genome sequences, with the exclusion of
substitutions predicted to be in recombinant regions (McCann et al., 2017).
1.1.4 Psa virulence
The damage Psa has caused to the kiwifruit industry and dependent communities
highlights the importance of understanding the basis of its virulence. This is particu-
larly relevant to strains of the global pandemic lineage. Comparative genomics has led
to the identification of lineage specific genes such as those encoding type III e↵ector
proteins (Marcelletti et al., 2011; McCann et al., 2013). Inferring from existing data
of other plant pathogens, such as P.s pv. syringae, a greater knowledge of Psa e↵ector
proteins can be gained.
HopZ5 has been identified as a unique type III e↵ector in Biovar 3 strains (McCann
et al., 2013). Studies have shown that Biovar 3 Psa HopZ5 localises in the plasma
membrane of Arabidopsis and Nicotiana species where it elicits a hypersensitive re-
sponse (HR) from the plant (S. Choi et al., 2017; Jayaraman et al., 2017). It was
demonstrated that Biovar 3 Psa HopZ5-triggered HR activity is linked to its acetyl-
transferase capability likened to HopZ family members in P.s pv. syringae (Jayaraman
et al., 2017). Further, P.s pv. syringae HopZ5 homologue also localises in the plant
plasma membrane (S. Choi et al., 2017; Jayaraman et al., 2017). Taken together, this
can give insight to possible host targets and mode of action which may contribute
to virulence in Psa. However, these experiments were conducted in Arabidopsis and
Nicotiana species, therefore, the response of Actinidia with Psa type III e↵ectors may
be di↵erent.
It is also evident that the phaseolotoxin gene cluster found in Biovar 1 strains and
the coronatine gene cluster found in Biovar 2 strains are not the only indicators
of virulence. While Biovar 1 and Biovar 2 strains caused huge losses in respective
kiwifruit growing regions, Biovar 3 strains do not produce either toxin yet, remain
highly virulent (Mazzaglia et al., 2012). The gene clusters are also absent in Biovar 5
strains (Fujikawa & Sawada, 2016), whereas Biovar 6 strains harbour both (Sawada
et al., 2016). Presently, the virulence levels of Biovar 5 and Biovar 6 strains compared
to other lineages are not well determined.
8
Often plasmids, ICE elements and other horizontally transferred components carry
genes that may contribute to virulence (Marcelletti et al., 2011; Butler et al., 2013;
McCann et al., 2013). It is hypothesised that the unique 74 kb plasmid present in
the pandemic lineage contributes greatly to its pathogenicity. It has been suggested
to harbour three type III e↵ectors and other lineage specific genes (McCann et al.,
2013). However, two of the three type III e↵ector genes are interrupted with IS trans-
posases and are therefore inactive. The coronatine gene cluster present in Korean
Biovar 2 strains is also thought to be plasmid borne (Han et al., 2003). Like plas-
mids, ICE elements are transferred through conjugation (Burrus et al., 2002). Butler
et al. have shown that di↵erent Pac ICE found in the Italian, Chilean and New
Zealand strains of the pandemic lineage contain a C4 dicarboxylate transporter, inor-
ganic pyrophophatase, enolase, a voltage gated chloride channel and methyl accepting
chemotaxis protein, all of which may have a phenotypic e↵ect on the pathogen (Butler
et al., 2013).
1.1.5 Antimicrobial resistance in Psa strains
The rise of copper and streptomycin resistant Psa in New Zealand poses a threat
due to the possibility that the current methods of control may become ine↵ective
(Kiwifruit Vine Health, 2015; Poulter et al., 2016; Colombi et al., 2017). These re-
sistances can be attributed to horizontal transfer of resistance encoding genes into
Psa (von Wintersdor↵ et al., 2016). Application of antimicrobial copper in the field
means that not only is Psa being exposed, but rather the entire microbial commu-
nity within the kiwifruit orchard. This selective pressure allows the development of
copper resistance genes to spread within the community. Analysis of Psa from the
initial incursion showed that they were sensitive (Colombi et al., 2017). However, with
the continued exposure of copper, Psa in New Zealand have acquired gene cassettes
needed for high level copper resistance. These cassettes encode either copper e✏ux
(cusABC ) or sequestration (copABCD) mechanisms, along with their regulatory com-
ponents, copR and copS (Poulter et al., 2016; Colombi et al., 2017). These operons
have been found on megaplasmids and various ICE elements in New Zealand strains,
specifically Pac ICE9 and Pac ICE10 (Poulter et al., 2016). Besides copper resistance
gene cassettes, there are other genes on such megaplasmids and ICE elements where
function are unknown (Poulter et al., 2016). It would be of interest to explore these
genes in relation to their contribution to copper resistance. Furthermore, these ICE
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elements have been shown to be derived from P.s pv. actinidifoliorum (Poulter et al.,
2016). ICE elements from Psa have also been proven to successfully transfer to other
Pseudomonas such as P.s pv. actinidifoliorum and P.s pv. phaseolicola (Colombi
et al., 2017). This further illustrates how readily copper resistance is horizontally
transferred from one bacterium to another.
Streptomycin resistance has also emerged in New Zealand due to the presence of a
transposon conferring streptomycin resistance which is carried on plasmids (Kiwifruit
Vine Health, 2015; Colombi et al., 2017; Zhao et al., 2017)
Overseas a similar story of antimicrobial use and the emergence of resistance has been
recounted. The use of copper and streptomycin to control Psa has been occurring in
Japan for much longer, therefore it is unsurprising that resistant strains from several
di↵erent lineages have been detected (Nakajima et al., 2002; Poulter et al., 2017).
Biovar 1 Japanese strains were found to contain plasmids harbouring copper and
streptomycin resistance genes (Nakajima et al., 1995; Nakajima et al., 2002). One
such plasmid, pPaCu1, contains copper resistance genes with a high homology to
that found in P.s pv. tomato (Nakajima et al., 2002). Furthermore, the plasmid
pMAFF212063-A described in copper resistant Biovar 5 strains were found to be
highly similar to pPaCu1, with 99.9% identity match reported (Poulter et al., 2017).
In addition to copper resistance genes, a streptomycin-encoding transposon is also
present on pMAFF212063-A (Poulter et al., 2017).
Other examples of heavy metal resistance genes have been detected, such as arsenic
resistance. Butler et al. have found that Pac ICE2 in Biovar 3 Italian strains carry
three arsenate resistance genes, reflecting their ability to grow on 5 mM sodium arse-
nate compared to 0.5 mM arsenate of other strains without such genes (Butler et al.,
2013). This was also explored by Ferrante et al. (Ferrante et al., 2015).
In addition to Psa strains harbouring antibiotic and heavy metal resistance, there is
evidence of mechanisms that further increase tolerance to antibiotics. Whole genome
sequencing analysis have revealed the presence of drug e✏ux transporters in Bio-
var 1 and Biovar 3 strains (Marcelletti et al., 2011). Alone, e✏ux transporters may
not provide significant antimicrobial resistance, but in conjunction with other resis-
tance mechanisms, the additional e↵ect of e✏ux transporters may prove considerable
(Webber & Piddock, 2003).
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1.2 Exploration of virulence and antimicrobial re-
sistance with CRISPR/Cas9 in Psa
This study looked to introduce a CRISPR/Cas9 system, now a commonly used genome
editing tool, into Psa, enabling the selective inactivation of specific genes or even
whole plasmids/ICE elements. CRISPR/Cas9 could be a valuable tool in exploring
the genetic basis of virulence and antimicrobial resistance in Psa.
CRISPR/Cas9 is a breakthrough genome editing tool with its specificity based on
RNA complementarity. The native prokaryotic CRISPR/Cas system primarily acts
as a defence system against unwanted invaders such as phages, with many bacteria and
archaea carrying a Cas protein operon and a CRISPR (clustered regularly interspaced
short palindromic repeats) array downstream (Haft et al., 2005). The CRISPR array
comprises of short repeats separated by unique sequences called ‘spacers’ which are
derived from past invaders (Barrangou et al., 2007; Makarova et al., 2006). When
encountering new foreign invaders, a novel spacer will be added to the array, allowing
a rapid immune response if the host re-encounters the same invader. When this
recurrence takes place, the CRISPR array is transcribed into the pre-crRNA (CRISPR
RNA) where it is processed into a shorter mature crRNA (Haft et al., 2005). The
crRNA guides the Cas protein to cleave a specific target sequence, resulting in the
silencing of the foreign DNA (Brouns et al., 2008). Adjacent to the complementary
region of the crRNA is the Protospacer Adjacent Motif (PAM) sequence, which the
Cas protein requires to successfully bind and cleave the target DNA.
Since its discovery as a prokaryotic adaptive immune system, the CRISPR/Cas system
has been engineered to carry out a variety of applications, with the generation of
specific modifications being the most notable (Barrangou et al., 2007; Jinek et al.,
2012). This application has been successful in a variety of organisms, such as plants,
animals and bacteria (reviewed in Doudna and Charpentier, 2014). The elegance of
the system allows researchers to specifically target any region of the genome by simply
changing the crRNA target sequence.
The CRISPR/Cas system have been divided into two di↵erent classes on the basis of
the Cas proteins. It is then further divided into types and subtypes (Makarova et al.,
2015). The class II, type II system has been widely manipulated into a gene editing
tool because only a single Cas protein (Cas9) is required for cleavage rather than
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multiple (Jinek et al., 2012). It also requires a trans-activating CRISPR RNA (tracr-
RNA) for crRNA maturation and DNA cleavage. The crRNA and tracrRNA have
corresponding direct repeats, enabling the two components to interact within one an-
other. In some instances, the crRNA and tracrRNA are fused into a single guide RNA
(sgRNA). This complex goes on to interact with the Cas9 protein which subsequently
cleaves the target sequence, resulting in double stranded breaks (DSBs) (Figure 1.2).
This is repaired by mechanisms endogenous to the cell such as non-homologous end
joining (NHEJ) or homology directed repair (HDR) (Jinek et al., 2012; Doudna &
Charpentier, 2014). The employment of NHEJ for DSB repair is often error-prone,
leading to insertions/deletions and frame shifts. In the context of CRISPR/Cas9 gene
editing studies, these errors are intended as site-directed mutagenesis. In contrast,
HDR requires a template which allows for precise restoration of the DSB which can
be useful for specific deletions/insertions and modifications (Doudna & Charpentier,
2014). Thus, this technology can be used to target virulence or resistance related
genes in Psa.
Figure 1.2: Interference of target sequence with CRISPR/Cas9 system
The CRISPR-Cas9 system consists of a sgRNA:Cas9 protein complex. The sgRNA
forms secondary structures enabling it to interact with the Cas9 endonuclease. The
sgRNA also base pairs with the target sequence, guiding the Cas9 endonuclease to
cleave the target DNA. A PAM sequence is also required for recognition and is
located downstream of the target sequence. There are instances where the sgRNA
exists as two RNA components; tracrRNA and crRNA. The DSB can be repaired
either by HDR or NHEJ. Figure from Tian et al. 2017.
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1.2.1 CRISPR/Cas9 in bacteria
To date, the application of CRISPR/Cas gene editing studies in bacteria have been
limited (reviewed in Selle and Barrangou, 2015; Luo et al., 2016; Tian et al., 2017).
This problem is likely to stem from the poor capability of bacteria to repair CRISPR
generated DSBs, often proving lethal to the cell (Luo et al., 2016). Given the defensive
nature of the native system, it seems counteractive to repair such breaks at a high
e ciency as speculated by Luo et al. Due to low repair e ciency of endogenous repair
systems, the utilisation of CRISPR/Cas9 is often coupled with recombineering using
the likes of the  -Red system to mediate recombination (Tian et al., 2017). There
are also instances where CRISPR/Cas9 is used as counter-selection for cells that have
not incorporated the desired modification (reviewed in Tian et al., 2017).
It is widely suggested that most prokaryotes are restricted to only HDR to repair
DSBs. In contrast, eukaryotic cells have two repair mechanisms for DSBs at their
disposable; HDR and NHEJ. The eukaryotic NHEJ repair system involves a number
of components including the Ku protein which binds to the damaged ends of the DNA
(Wyman & Kanaar, 2006). Another important factor is the ATP-dependent DNA
ligase (Wyman & Kanaar, 2006). The application of CRISPR/Cas9 in bacteria was
first reported in 2013 where an oligonucleotide template was introduced to promote
HDR in Streptococcus pneumoniae and a recombineering strain of E. coli (Jiang et al.,
2013). Since then a number of bacterial CRISPR/Cas9 studies have been completed
that also exploits HDR (reviewed in Tian et al., 2017).
The majority of bacterial species do not display NHEJ activity, with the most notable
example being E. coli (Bowater & Doherty, 2006). However, a growing number of bac-
teria have been shown to harbour Ku and ATP-dependent DNA ligase (LigD) homo-
logues, proteins required for the two-component bacterial NHEJ machinery (Bowater
& Doherty, 2006). This first came to light inMycobacterium where approximately 50%
of DSBs were repaired erroneously indicating the presence of a NHEJ system (Gong
et al., 2005). Similar to eukaryotic systems, the bacterial Ku is predicted to bind to
damaged DNA ends, recruiting the associated DNA ligase (reviewed in Shuman and
Glickman, 2007). The complex works to repair the DSB. In some bacteria, such as
Mycobacterium and P. aeruginosa, the ligase polypeptide contains a polymerase and
nuclease domain in addition to the ligase domain (Gong et al., 2004; Zhu & Shuman,
2005b). In contrast, eukaryotes employ separate gene products to perform these steps
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(Lieber, 2010).
In relation to CRISPR/Cas9 gene editing studies, NHEJ repair of Cas9 generated
DSBs has been limited. Tong et al. was first to report this in Streptomyces coelicolor
(Tong et al., 2015). S. coelicolor has an incomplete NHEJ pathway. Therefore, a
ligD gene from a related Streptomyces species was expressed, giving high e ciency of
NHEJ repair (Tong et al., 2015).
1.2.2 NHEJ in bacteria
Since the discovery of a NHEJ pathway in Mycobacterium, e↵orts to identify Ku and
associated DNA ligase homologues in other bacteria species have progressed (Bowater
& Doherty, 2006). In fact, a surprising number of species have been found to have
a Ku homologue, considered to be a marker for NHEJ activity (Bowater & Doherty,
2006). This is summarised in Figure 1.3. Often, Ku and ATP-dependent ligase genes
are organised in an operon suggesting coupled functionality (Bowater & Doherty,
2006).
P. aeruginosa was the first Pseudomonas with Ku and LigD proteins identified and
characterised (Zhu & Shuman, 2005a, 2005b, 2010). The LigD protein was shown to
be able to extend and resect DNA ends by several bases to allow for blunt ligation
(Zhu & Shuman, 2005a, 2005b, 2010). These are generally considered hallmarks of
NHEJ. More recently, P. putida was also found to employ NHEJ to repair DNA during
stationary phase (Paris et al., 2015).
A variety of Psa strains have been fully sequenced and annotated. This revealed,
for the first time, the presence of Ku and ATP-dependent ligase genes arranged in
an operonic manner in a majority of Psa genomes. For example, the Japanese Psa
strain ICMP 9853, contains a coding sequence annotated as ‘Ku protein’ positioned
at 2,397,580 bp to 2,398,479 bp. This is followed by an ATP-dependent DNA ligase
at 2,398,500 bp to 2,401,055 bp. The presence and organisation of these two genes
suggest the probability of NHEJ in Psa.
The presence of two di↵erent repair mechanisms may be able to broaden the applica-
tion of CRISPR/ Cas9 in Psa and other bacterial species.
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Figure 1.3: Phylogenetic distribution of Ku protein in Bacteria
Green stars indicate phyla that contain homologues of Ku. Blue stars indicate
classes/orders that contain homologues of Ku. Corresponding green and blue
numbers indicate the number of species with completed genome sequences that are
within each phylum/class that contain one (or more) homologue(s) of Ku. Red stars
indicate families that contain homologues of Ku. Note that there is no instance in
which a Ku homologue is contained in all species within a phylum/class. Figure from
Bowater and Doherty, 2006
1.2.3 Prior work on CRISPR/Cas9 in Psa
Previous attempts to introduce CRISPR/Cas9 into Psa, specifically the New Zealand
pandemic strain ICMP 18708, have been unsuccessful (Zhao, 2015). Methods to
transform Psa were developed based on the P. aeruginosa plasmid pUCP22, which
is transferable via electroporation and selectable with antibiotics. This plasmid is a
shuttle vector designed to replicate in E. coli and Pseudomonas (West et al., 1994).
The Streptococcus pyogenes derived CRISPR/Cas9 elements from the pCas9 plasmid
(Jiang et al., 2013) were combined with pUCP22 to give the pMZ series of plasmids
(Zhao, 2015). These plasmids were e↵ective in transformations into E. coli DH5↵.
However, transformation of Psa was unsuccessful (Zhao, 2015). The few transformants
observed in Psa carried a variety of large deletions in the Cas9 encoding region (Zhao,
2015). While this was an unexpected and undesirable result, it confirmed the presence
of a NHEJ system in Psa. To identify the problem within the plasmid, di↵erent
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CRISPR/Cas9 fragments were cloned into pUCP22. The four fragments are detailed
in Figure 1.4. It was clear certain CRISPR/Cas9 regions prevented the plasmid’s
successful uptake (Table 1.2). It was hypothesised these particular regions harboured
motifs recognised by the restriction modification (RM) systems of Psa. In fact, two
type I restriction sites of ICMP 18708 were found at position 2,968 bp and position
4,547 bp of the CRISPR/Cas plasmid (Zhao, 2016). Despite altering these two sites,
transformation of the plasmid into Psa was still extremely limited (Zhao, 2016).
Figure 1.4: Fragments of the CRISPR/Cas9 plasmid cloned in pUCP22
Four fragments of the CRISPR/Cas9 plasmid, pMZ2, were individually cloned into
pUCP22 and transformed into Psa to identify the region preventing uptake. Figure
created on Geneious 10.1.3 (Kearse et al., 2012). Data from Zhao, 2015.
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Table 1.2: Ability of di↵erent fragments of the CRISPR/Cas9 plasmid to transform
Size (bp) Position in pMZ2 (bp) E. coli DH5↵ Psa
pUCP22 4,729 N/A + +
pMZ2 9,298 N/A + -
Fragment 1 1,376 2,004 - 3,379 + +
Fragment 2 1,474 3,261 - 4,735 + -
Fragment 3 1,275 4,595 - 5,869 + -
Fragment 4 1,052 5,805 - 6,857 + +
Data from Zhao, 2015.
1.3 Restriction modification systems
RM systems are innate defence mechanisms found in prokaryotes, typically consisting
of a restriction endonuclease and DNA methyltransferase (Figure 1.5). The restriction
endonuclease can cleave specific sequences of foreign DNA such as invading phages
and plasmids. To prevent the resident DNA from being cleaved, the same recognition
sites are methylated by the cognate methyltransferase (Blumenthal & Cheng, 2002).
Depending on the type of RM system, the mechanism of recognition and cleavage will
vary.
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Figure 1.5: Restriction modification (RM) systems
RM systems act as a defence system against foreign invaders such as bacteriophages.
In brief, RM systems typically consist of a restriction endonuclease (REase) and
DNA methyltransferase (MTase). The restriction endonuclease disables the invader
by recognising and cleaving a specific DNA sequence. To protect the resident DNA
from being cleaved, the methyltransferase will methylate the same recognition site in
its own genome. Figure from Vasu and Nagaraja, 2013.
1.3.1 Types of restriction modification systems
In order to determine and circumvent the RM modification systems, di↵erent Psa
genomes were studied to reveal what restriction systems were present. There are a
number of di↵erent types of RM systems recognised.
Type I systems (reviewed in Dryden et al., 2001 and Loenen et al., 2013) are com-
prised of three di↵erent subunits; hsdR (restriction), hsdM (modification) and hsdS
(specificity). The hsdS subunit confers DNA specificity to both hsdR and hsdM by
recognising a specific bipartite sequence. The three subunits form a complex which
binds to the recognition site. The translocation of DNA in a unidirectional manner
occurs whilst the type I complex remains attached to the site. Consequently, the
formation of DNA loops can be observed (Yuan et al., 1980). DNA is cleaved by the
hsdR subunit when translocation stalls which occurs at various distances from the
recognition site.
Type II systems are the most widely studied RM system, being used in biotechnology
and biological research for decades (reviewed in Pingoud et al., 2005). They are
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generally composed of an independent methyltransferase and restriction endonuclease.
Type II systems typically recognise a palindromic sequence and cleave at the site
of recognition. However, some subgroups combine both enzyme functions into one
polypeptide and cleave away from site of recognition such as type IIG RM systems
(Janulaitis et al., 1992). Furthermore, these subgroups may recognise non-palindromic
sites.
There are also type III systems (reviewed in Dryden et al., 2001 and Rao et al., 2013)
which recognise a 5-6 bp non-palindromic sequence. For cleavage to occur, it requires
two sites arranged in opposite orientation. The complex will bind to the recognition
sequences and translocate towards each other until collision occurs thereby triggering
cleavage. This usually happens 25-28 bp away from the recognition sequence.
The New Zealand pandemic Psa strains ICMP 18708 has been shown to contain
two RM systems; a type I and type II system which recognises AGCAN5GTC and
CTCGAG sites, respectively (Templeton et al., 2015). Restriction sites were inferred
from single molecule real-time sequencing (SMRT) developed by Pacific Biosciences
(PacBio). In the present study, the RM systems of other Psa were also determined
using PacBio sequencing.
1.3.2 SMRT PacBio sequencing
In order to comprehend the hypothetical RM systems cutting the CRISPR/Cas9 plas-
mid, it was necessary to determine what RM systems occurred in Psa. Once this was
determined, the CRISPR/Cas plasmid was modified to remove any such restriction
sites. To detect the recognition sites of RM systems, SMRT PacBio sequencing was
employed (Davis et al., 2013). In addition to generating objectively longer sequencing
reads, the technology can identify DNA modifications such as methylation generated
by RM systems.
The mechanism of DNA methylation detection is integral to how the technology cap-
tures sequence information. In short, the template DNA being sequenced has hairpin
adapters ligated on both ends allowing the template to form a closed one-stranded
circular DNA molecule without a↵ecting DNA methyl marks. This is known as the
SMRTbell. A single polymerase is used and binds the DNA molecule. The poly-
merase then incorporates a fluorescent-tagged nucleotide one at a time to the read
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strand. When a new nucleotide is held by the polymerase, a light pulse is produced
that allows identification of the base at real time (Figure 1.6) (Eid et al., 2009).
Often observed in bacterial genomes are 6-methyladenine (6mA), 4-methylcytosine
(4mC), and 5-methylcytosine (5mC) (Ratel et al., 2006). PacBio sequencing can
detect this by monitoring how long it takes bases to be incorporated, termed inter-
pulse durations (IPDs) (Figure 1.6) (Davis et al., 2013). As modifications cause
temporary stalling and increased IPDs, the di↵erences of IPDs between normal and
methylated bases allows detection of modified bases.
Figure 1.6: Detection of methylated bases in PacBio sequencing
PacBio sequencing can detect modified bases by monitoring the time variation in
which bases are incorporated, for example, 6mA in the template strand delays the
incorporation of the complementary T nucleotide. In comparison, the addition of a
T nucleotide opposite an unmodified A nucleotide in the template strand has a
shorter IPD. a.u. stands for arbitrary unit. Figure from Pacific Biosciences, 2015.
1.4 CRISPR/Cas plasmid base composition
Another unusual feature of the S. pyogenes CRISPR/Cas elements is the base com-
position. The genome of S. pyogenes has a GC content of approximately 38.5%
(Maruyama et al., 2016) which is reflected in the GC composition of the CRISPR/Cas
structure. Considering Psa has an average GC content of 58%, the unusual base com-
position of the CRISPR/Cas elements could result in a higher level of secondary
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structure formation. This may lead to instability during replication and possibly
recombination of the plasmid in Psa but evidently not E. coli. Reviewing and re-
adjusting the GC composition of the CRISPR/Cas9 elements to be more align with
that of Psa could be advantageous.
1.5 Project aims
The purpose of this project was to introduce the CRISPR/Cas9 system into Psa.
This was explored through a number of ways, including utilising conjugation and
restriction alleviation as a means for the CRISPR/Cas9 to circumvent RM systems
which were hypothesised as preventing plasmid uptake. The Psa RM systems were
analysed with PacBio sequencing. This Pacbio analysis guided the alterations required
to remove identified restriction recognition sites. Further, comparison of a variety of
Psa genomes allowed the detection of any additional RM systems. The study also
led to the exploration of the unconventional GC content of the S. pyogenes derived
CRISPR/Cas9 components. This involved the re-synthesis of a section of the Cas9
encoding gene, modified to be more reflective of the GC content found in Psa. The
project showed that a CRISPR/Cas9 plasmid is capable of transformation into E. coli
and Psa.
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2. Methods and Materials
2.1 Bacterial strains
E. coli DH5↵ was predominantly used for the propagation of plasmids. This strain
was also used as a recipient in conjugation experiments. The donor strain used for
conjugative transfer was E. coli S17-1 (provided by the Lamont laboratory from the
Department of Biochemistry, University of Otago). Pseudomonas strains used in this
study are listed in Table 2.1.
Table 2.1: Pseudomonas strains
Organism Strain Origin Year of Psa WGS
isolation Biovar reference
Psa ICMP 18708 New Zealand 2010 3 Butler et al., 20131
Psa M228 China 2010 3 Butler et al., 20131
Psa K4 South Korea 2014 2 This work
Psa ICMP 9853 Japan 1984 1 Butler et al., 20131
P.s pv. theae ICMP 3923 Japan 1974 N/A This work
1Illumina sequencing
2.2 DNA extraction, genome sequencing and as-
sembly
Fully assembled Pseudomonas genomes listed in Table 2.1 were available for analysis.
This involved the extraction of genomic DNA from a pure bacterial culture to generate
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a PacBio sequencing library. This required high quality and high molecular weight
genomic DNA. The Japanese strain ICMP 9853 and Chinese Psa strain M228 Pacbio
sequencing reads were provided by the company Macrogen (Macrogen; Seoul, Korea;
http://www.macrogen.com). The reads were also assembled by Macrogen (Macrogen;
Seoul, Korea; http://www.macrogen.com) using HGAP3. The initial assemblies for
both strains were error corrected using lllumina sequencing reads. Illumina library
preparation and sequencing were performed by NZGL (http://www.nzgenomics.co
.nz) at the University of Otago.
PacBio sequencing of the New Zealand Psa strain ICMP 18708, the Korean Psa strain
K4 and P.s pv. theae ICMP 3923 were completed by Macrogen and assembled using
HGAP3 at the University of Otago. The initial assembly for the New Zealand Psa
strain ICMP 18708 was error corrected using lllumina sequencing reads. The Korean
Psa strain K4 and P.s pv. theae ICMP 3923 have yet to be error corrected.
2.3 Modification detection and restriction site mo-
tif analysis
Macrogen (Macrogen; Seoul, Korea; http://www.macrogen.com) also provided mod-
ification detection and motif analysis data for the Japanese Psa strain ICMP 9853
and Chinese Psa strain M228.
Draft genomes assembled from PacBio sequencing of the Korean Psa strain K4 and
P.s pv. theae ICMP 3923 were available for analysis. Methylation detection and motif
analysis data were gathered using the SMRT analysis software via SMRT portal. The
protocol RS Modification and Motif Analysis.1 was carried out. This consisted of
PacBio sequencing reads realigned to the PacBio reference genome. PacBio sequencing
holds polymerase kinetics data, therefore, realigning to the reference genome will allow
modified bases to be identified and located in the context of the reference genome,




The plasmids utilised are indicated in Table 2.2.
Table 2.2: Plasmid vectors and constructs
Plasmid Size (bp) Relevent features Reference
pUCP22 4,729 AmpR; GmR; Lac ↵ peptide West et al., 1994
pEX18Gm 5,831 GmR; conjugative origin of transfer Hoang et al., 1998
pGEM-t easy 3,015 AmpR, Lac ↵ peptide Promega
pET24(+) 5,236 KanR Novagen
pMZ3 9,298 AmpR; CRISPR/Cas9 elements Zhao, 2016
pMZ3+↵pep 10,383 AmpR; CRISPR/Cas9 elements; This work
Lac ↵ peptide
pMZ3+oriT 10,676 AmpR; CRISPR/Cas9 elements; This work
conjugative origin of transfer
pUCP22+oriT 6,093 AmpR; GmR; conjugative origin of This work
transfer
pMZ4 9,083 KanR; CRISPR/Cas9 elements This work
pMZ44NdeI 7,648 KanR; CRISPR/Cas9 This work
(with deletion)
pMZ44BamHI 7,734 KanR; CRISPR/Cas9 This work
(with deletion)
pUC57+NdeI 3,997 KanR; synthetic Cas9 NdeI fragment Genscript
pUCP22+NdeI 6,149 AmpR; GmR; synthetic Cas9 NdeI This work
fragment
pMZ5 9,083 KanR; CRISPR/Cas9 capability; This work
synthetic NdeI fragment
2.5 Growth Media
All media were prepared with distilled water and autoclaved at 15 psi for 15 minutes to
sterilise. To make solid media, the media components were sterilised separately from
agar and combined to give a final 1.5% agar (w/v) and correct media composition.
The media were poured into agar plates and left to cool.
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Luria medium (per litre): 10 g BactoTM tryptone, 5 g yeast extract, 10 g NaCl. Luria
medium was used for the growth of E. coli.
King’s B medium (per litre): 20 g peptone, 20 g glycerol, 1.5 g K2HPO4. 1.5 g
of sterile 1 mM MgSO4 was added after other components were autoclaved. This
prevented the precipitation of MgSO4. Kings B medium was used for the growth of
Pseudomonas.
 B medium (per litre): 20 g BactoTM tryptone, 5 g yeast extract, 0.75 g KCL, KOH-
adjusted to pH 7.6. 35 ml of sterile 1 mM MgSO4 was added after other components
were autoclaved for 45 minutes at 15 psi.  B medium was used for the production of
competent E. coli DH5↵ cells.
When antibiotic selection was needed either 200 mg/L ampicillin, 10 mg/L cefo-
taxime, 4 mg/L gentamicin, 200 mg/L ticarcillin, 50 mg/L kanamycin or 50 mg/L
trimethoprim was added to solid or liquid media.
When blue/white colony selection was needed for E. coli 20 µl each of 40 mg/ml
BCIG in DMF and 40 mg/ml IPTG in ddH2O was spread over each Luria plate prior
to plating of cells.
E. coli and Pseudmonas strains were grown at 37  C and 28  C, respectively.
2.6 Gel electrophoresis
0.8% (w/v) agarose gels was used. The agarose (Sigma-Aldrich) was added to 50 ml of
bu↵er. This was subsequently heated in the microwave until the agarose was dissolved.
It was poured into the gel electrophoresis tank with the well comb in place and left
to cool. Bu↵er was added to the gel tank until the agarose gel was submerged. The
well comb was removed and DNA samples were loaded into the wells. The agarose
gels were run for ⇠45 minutes at 60 v or until satisfactorily separated. The bu↵er
consists of: 195 ml ddH2O, 5 ml TAE bu↵er and 10 µl 10 mg/ml ethidium bromide
(Sigma-Aldrich).
TAE bu↵er (per litre) consists of 100 ml 0.5 mM EDTA, 242 g tris-HCL and 57.2 ml
glacial acetic acid, with the final bu↵er being pH 8.
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1 kb ladder (Roche) was used to indicate band sizes between 0.5 kb and 10 kb (Figure
2.1).
Figure 2.1: 1 kb molecular weight marker.
Band sizes are indicated in kilobases (kb).
2.7 Restriction enzyme digest
The following reagents were added into microcentrifuge tubes:
1 µl appropriate restriction enzyme
1 µl appropriate bu↵er
7 µl template
enough ddH2O to make up 10 µl total volume
Restrictions were incubated at the appropriate temperature for an hour. When de-
sired, the restriction enzymes were inactivated in the appropriate manner. The reac-
tion conditions for the enzymes used are outlined in Table 2.3. All restriction enzymes
were sourced from New England BioLabs. Bu↵er preference of the di↵erent restriction
enzymes are found on the New England BioLabs website. StrataClean resin (Agilent
Technologies) was used for enzymes that cannot be inactivated via high temperature.
An agarose gel was run to visualise the products of the restriction digests.
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Table 2.3: Restriction enzymes utilised and their reaction conditions
Enzyme Sequence 5‘-3‘ Incubation Inactivation
temperature ( C) temperature ( C)
AflII C/TTAAG 37 65
BamHI G/GATCC 37 N/A
ClaI AT/CGAT 37 65
EcoRI G/AATTC 37 65
Nar I GG/CGCC 37 65
NdeI CA/TATG 37 65
SacI GAGCT/C 37 65
SalI G/TCGAC 37 65
ScaI AGT/ACT 37 80
SpeI A/CTAGT 37 80
XbaI T/CTAGA 37 65
XhoI C/TCGAG 37 65
2.8 Polymerase chain reaction (PCR)
PCR reactions were performed at 35-50 cycles using the Eppendorf PCR thermal
cycler machine. The PCR product generated was analysed through gel electrophoresis.
Template DNA was either produced from 5 ml overnight of culture or from ‘colony
cracks’ of individual colonies (see section 2.9). Table 2.4 outlines the reagents required
for the di↵erent PCR reactions. Table 2.5 details the primers used in this project.
All primers were sourced from Sigma-Aldrich where it is provided dry. This was re-
suspended in enough volume of ddH2O to give a concentration of 200 µM. This is the
primer stock. A 1 in 20 dilution of the primer stock with ddH2O was completed to
give the working stock at a concentration of 10 µM.
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Table 2.4: PCR reaction mixtures
Colony PCR (µl) Cloning (µl)
Template 2 3
Either 2x ReddyMix PCR Master Mix1 5 25
or DreamTaq Green PCR Master Mix1
ddH2O 2 25
10 µM forward primer 0.5 1
10 µM reverse primer 0.5 1
Final volume 10 50
1Sourced from Thermo Fisher Scientific. Taq DNA Polymerase, dNTPs, reaction
bu↵er and magnesium chloride are all present in both mixes. Also present is a dye
to facilitate gel loading unique to the respective PCR Master Mix.
Table 2.5: PCR and sequencing primers
Name Template Synthetic Sequence 5’-3’1
restriction
sites
AflII oriT F pEX18/pMZ3+oriT/ AflII gcgcgcCTTAAGgtactgtgttagcggtctgc
pUCP22+oriT
XhoI oriT R pEX18/pMZ3+oriT/ XhoI gcgcCTCGAGaagcagaaggccatcctga
pUCP22+oriT
SpeI oriT F pEX18/pMZ3+oriT/ SpeI gcACTAGTgtactgttagcggtctgc
pUCP22+oriT
SpeI oriT R pEX18/pMZ3+oriT/ SpeI gcACTAGTaagcagaaggccatcctgac
pUCP22+oriT
↵ peptide F pGEM-t easy XbaI/AflII gcTCTAGACTTAAGgacttgagcgtcg
↵ peptide R pGEM-t easy XbaI/XhoI gcTCTAGACTCGAGggactccaacgtc
Ex oriT F pMZ3+oriT - ctgacgctcagtggaacg
Ex oriT R pMZ3+oriT - gcattggtaactgtcagac
XbaI Kan F pET24(+) XbaI gcTCTAGAtctgacgctcagtggaac
NarI Kan R pET24(+) Nar I gcgGGCGCCtcaggtggcacttttcgg
pCas-Bam rev pMZ plasmids - caccttagcaaccactag
F1 pMZ plasmids XmaI cgCCCGGGtgcgctcatcgtcatcctcg
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Rev1 pMZ plasmids SalI gcGTCGACctaattcatggatcagctgc
F2 pMZ plasmids XmaI cgCCCGGGtctcattgctcagctcccc
F2-2 pMZ plasmids - cgctacgatgaacatcatc
R2-1 pMZ plasmids - gccgttgtcaaaggtccg
R2-2 pMZ plasmids - gcaaatcatggtaggtacc
R2-3 pMZ plasmids - ctatcatcatggatcagctgc
F3-3 pMZ plasmids XmaI cgCCCGGGcgtggaggtttgagtgaac
Rev3-1 pMZ plasmids SalI gcGTCGACggaacaatgtgatcgac
R3-1A pMZ plasmids SalI gcGTCGACatcagaacgcgttaagacc
R3-2 pMZ plasmids SalI gcGTCGACgtattcatgcgactatcc
Rev3 pMZ plasmids SalI gcGTCGACtctcgccctttatcccagac
6784-rev pMZ plasmids - gatgctgtcggaatggacg
F4 pMZ plasmids XmaI cgCCCGGGcgcaaacgccctctaatcg
M13 F pUCP22 - cccagtcacgacgttgtaaaacg
M13 R pUCP22 - agcggataacaatttcacacagg
1Restriction sites are indicated in capitals and preceded by two/three bases 5’ to the
restriction site. This is a requirement for most of these endonucleases.
2.9 Colony ‘crack’ PCR screening
100 µl ddH2O was added into microcentrifuge tubes. A toothpick was used to sample
individual colonies. The samples were mixed with water in the microcentrifuge tubes
and frozen at -80  C for 30 minutes. The tubes were then heated in a 37  C water
bath for 5-10 minutes to lyse cells. The sample was used directly as a template for
PCR reactions.
2.10 PCR product purification
The QIAgen QIAquick PCR Purification Kit (QIAgen) was used to purify PCR prod-
ucts. It was carried out as per the manufacturer’s instructions. This kit produced
DNA free of RNA, primers and other contaminants.
29
2.11 Ligation
For self ligation reactions, the following reagents were added into a microcentrifuge
tube:
1 µl T4 DNA ligase (Roche)
1 µl Ligase Bu↵er (Roche)
1 µl 1 mg/ml Acetylated BSA (Roche)
1 µl 1 mg/ml rATP (Sigma-Aldrich)
6 µl Template DNA
10 µl Total volume
For the ligation of an insert into a vector, the same reagents were added into the
microcentrifuge tubes. However, instead of 6 µl of template, a 1:3 molar ratio of
vector to insert was added. Enough ddH2O was added to make 10 µl total volume.
After the reagents were combined for either self-ligation or ligation of an insert into a
vector, they were incubated at room temperature overnight.
2.12 Production of competent E. coli DH5↵
10 ml of  B medium was inoculated with a single colony of E. coli DH5↵. This was
incubated at 37  C at ⇠250 RPM until OD550=0.3 (⇠2-3 hours) was reached. 5 mL
were transferred to 100 ml of pre-warmed  B medium and then further incubated at
37  C at 250 RPM until OD550=0.45-0.55 (⇠2-3 hours). The cells were then chilled on
wet ice for 5 minutes. The rest of the protocol was completed at 4  C. The culture was
transferred into two 50 ml falcon tubes and pelleted by centrifugation at 3,000 RPM for
5 minutes. The supernatant was removed and the pellet was then re-suspended in 15
ml of TfBI. The re-suspended cells were immediately pelleted again by centrifugation
at 3,000 RPM for 8 minutes. The supernatant was removed and the pellet was re-
suspended in 2 ml of TfBII. 200 µl aliquots were snap-frozen in microcentrifuge tubes
using a dry ice-ethanol bath. The 200 µl aliquots of now competent cells were stored
at -80  C until needed. Based on methods by Green and Rogers, 2013.
TfBI (per 500 ml): 1.47 g KAc, 4.95 g MnCl2, 6.05g RbCl, 0.74 ml glycerol and
KOH-adjusted to pH 7.6. This bu↵er was stored at 4  C. Often TfBI will produce
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a small amount of rust coloured precipitant, however, this will not negatively a↵ect
production of competent cells.
TfBII (per 100 ml): 10 ml of 100 mM MOPS (pH 7.0), 1.10 g CaCl2, 0.12 g RbCl,
15 ml glycerol. This bu↵er was stored at 4  C under tinfoil to prevent light induced
degradation.
2.13 Transformation via heat shock for E. coli DH5↵
An aliquot of chemically competent cells was thawed at room temperature until just
liquid. It was then held on wet ice for 5-10 minutes (maximum time of an hour).
DNA for analysis was added to a 50-100 µl aliquot of cells. ddH2O was added to one
aliquot as a negative control. These were mixed gently and incubated on ice for 30
minutes. The cells were heat shocked at 37  C for 2 minutes and subsequently held
on ice for another 3 minutes. 200 µl Luria broth was added and cells were incubated
at 37  C on 250 RPM shaker for ⇠1 hour. 100 µl of cells were plated on Luria agar
plates with the appropriate selections. Dilutions were made and plated as needed.
2.14 Transformation via electroporation for E. coli
and Psa
Methods used were based on the protocol by Choi et al. (K.-H. Choi et al., 2006).
Electroporation was performed using the Bio-Rad Gene Pulser Xcell machine. To
make electrocompetent cells, a liquid cell culture was grown overnight. To remove
excess salts, the cells were washed twice with 300 mM sucrose and re-suspended with
400 µl of 300 mM sucrose. To transform the cells, 50-500 ng/5 µl of plasmid was
added to a 100 µl cell aliquot and transferred into a 0.2 cm electrode gap electro-
poration cuvette. For a negative control, ddH2O was added to one sample of cells.
The samples were then electroporated at 25 uF, 200 Ohms and 2.5 kV. 1 ml of Luria
broth was immediately added and transferred to a microcentrifuge tube. The prepa-
ration was subsequently incubated for 2 hours at the appropriate temperature. The
transformants were plated on the appropriate media with the appropriate selection.
Dilutions were made and plated as needed.
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2.15 Filter paper conjugation
Overnight cultures of the donor and recipient strains were set up in 5 ml of appropriate
media. The overnight cultures were plated on the appropriate media until a distinct
lawn of bacteria formed. The bacteria was scraped o↵ from the plate to make a thick
suspension in 500 µl of ddH2O. The donor and recipient were mixed to make up a
1 ml suspension of bacteria in total. A sterile hypodermic syringe was used to force
the suspension though a sterile nitrocellulose filter (Merck millipore company). The
filter (pore size 0.45 µm) was placed on the appropriate media for ⇠16 hours in the
appropriate temperature. After the incubation, the filter paper was placed into 5 ml
of ddH2O in a 50 ml falcon tube. It was vortexed to wash o↵ cells. Dilutions were
made and plated as needed.
2.16 Plasmid isolation
The Roche High Pure Plasmid Isolation Kit (Roche) was used to isolate plasmids from
overnight cultures. This was carried out as per the manufacturer’s instructions. This
kit isolates relatively pure plasmid, free of chromosomal DNA and other contaminants.
2.17 Sequencing of plasmid and PCR samples
The Genetics Analysis Services in the University of Otago carried out the sequencing
of PCR and plasmid samples. Preparation methods of plasmid and PCR samples can
be found on http://gas.otago.ac.nz.
2.18 Gene synthesis of new NdeI fragment
During the analysis, it was suspected that the Streptococcus pyogenes CRISPR/Cas
structure was preventing the ability of the pMZ4 plasmid to be transferred intact into
Psa. It was hypothesised that the low GC composition of the fragment was causing
issues within Psa (but not E. coli). At an attempt to overcome this problem, a 1.4 kb
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fragment between two NdeI restriction sites of the pMZ4 plasmid was resynthesised
to have a higher GC content whilst retaining the same encoded amino acid sequence.
The GC composition was measured using Geneious 10.1.3 (Kearse et al., 2012). It
was also optimised for the E. coli preferred codon usage. The revised sequence was
sent to Genscript to be synthesised and placed into the vector pUC57-Kan. Further
analyses included exchanging the original NdeI fragment for the synthetic version in
the pMZ plasmid.
2.19 Sequence analyses
BLAST: Basic Local Alignment Search Tool is available through the NCBI (National
Centre for Biotechnology Information) website (https://blast.ncbi.nlm.nih.gov/
Blast.cgi). This tool was used to align DNA and protein sequences against available
online databases and reference sequences.
NEBcutter V2.0: The online software is provided by New England BioLabs (http://
nc2.neb.com/NEBcutter2/). The software was employed to identify restriction en-
zyme sites and defined oligonucleotides in plasmids and sequences of interest.
REBASE: The restriction enzyme database is available at http://rebase.neb.com
(Roberts et al., 2014). It holds comprehensive data of identified restriction modifi-
cation enzymes, detailing cleavage and recognition sites. Additionally, putative RM
systems are identified through sequence similarities.
Geneious 10.1.3: The software was used to visualise plasmid constructs and whole
genomes (http://www.geneious.com, Kearse et al., 2012). It was also used to align
sequences with MUSCLE, a multiple alignment software.
4peaks v1.8: The software was used to visualise and analyse the quality of sequencing
data (Griekspoor & Groothuis, 2006).
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3. Results
3.1 Restriction modification systems in Psa
Assemblies of Psa strains ICMP 18708 (New Zealand), ICMP 9853 (Japan), M228
(China), K4 (Korea) and P.s pv. theae ICMP 3923 were available for analysis. The
genomes were assembled from SMRT PacBio sequencing. The various Psa strains
analysed fall into di↵erent Biovars of Psa. By analysing the methylome data extracted
from PacBio sequencing, a broader understanding of the RM system repertoire from
an array of Psa strains was gained. A comparison of the genomes was also completed
to gain additional insight into Psa RM systems. Table 3.1 lists the predicted RM
systems in the Psa strains analysed. P.s pv. theae, a close relative of Psa, was also
analysed. PacBio sequencing only confirms the activity of DNA methyltransferase.
Further biochemical experiments would need to be conducted to prove restriction
endonuclease activity.
This data was also gathered to aid in the attempted introduction of the CRISPR/Cas9
plasmid into Psa. It was assumed that RM systems of Psa were one of the factors
preventing uptake.
34
Table 3.1: Predicted restriction modification systems in Psa and P.s pv. theae
Strain Putative Putative % of sites detected1
RM systems recognition sites
Psa ICMP 18708 Type I AGCAN5GTC 99.5/99.3
Type II CTCGAG 54.1/54.1
Psa ICMP 9853 Type III TCCACC 99.7
Type II CTGCAG 99.7
Psa M228 Type I GAYCN5CTGC 98.6/97.8
Psa K4 Type III/IIG GATCGAG 99.6
P.s pv. theae Type I AGGN4CCT 99.6
ICMP 3923 Type III GAAGAT 99.3
Type I TCCAN6CAT 99.5/99.2
Type II CTCGAG 77.8
1Percentage of sites detected below 50% were not included. Those with two values
are indicative of the complementary sequence that was also detected.
3.1.1 New Zealand strain ICMP 18708
The pandemic New Zealand (NZ) strain ICMP 18708 appears to contain two func-
tional RM systems, Psy18884I and Psy18884II recognising AGCAN5GTC and CTC-
GAG, respectively (Table 3.1) (Templeton et al., 2015). These RM systems were first
described in the New Zealand Psa strain ICMP 18884, a near identical Psa isolate of
ICMP 18708 (Templeton et al., 2015). Approximately 99% of the underlined adenine
bases in the AGCAN5GTC motif are modified in the NZ genome. In contrast, only
54% of the underlined cytosine sites in the CTGCAG motif are modified. This reflects
the lower detection rate of cytosine methylation of PacBio sequencing. In fact, it is
likely that all restriction sites in the genome are methylated to prevent self cleavage.
Psy18884I is described as a type I RM system, while Psy18884II is characterised as a
type II RM system. Other putative RM systems have also been reported by REBASE.
Proven and predicted RM systems found in the NZ strain are described in Figure 3.1.
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Figure 3.1: RM systems found in the New Zealand Psa strain ICMP 18708
Proven and predicted potential RM systems in the NZ genome are presented. A
white circle indicates RM systems that are likely to be non-functional. Adapted from
figures produced by REBASE (Roberts et al., 2014).
Type I RM system
Psy18884I is found at ⇠6 kb in the NZ genome ICMP 18708, with the DNA methyl-
transferase gene beginning at 6,593 bp. All positions are related to the sequence
of ICMP 18708 in GenBank (accession number of main chromosome is CP012179).
The type I system is encoded by the open reading frames (ORFs) NZ708 00025,
NZ708 00030 and NZ708 00035. These ORFs are predicted to encode the putative
proteins for modification, specificity and restriction, respectively.
To gain further insight into the RM systems of other Psa varieties, the NZ Psa genome
was compared with other Psa strains from di↵erent lineages. These comparisons
revealed a 58,232 bp region of significance within the NZ strain (Figure 3.2). Region
2 in the NZ strain harbours Psy18884I. The RM system, along with Regions 2-5,
are completely absent from the Japanese genome (Figure 3.2). This absent region is
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45,579 bp in length. The areas of shared conservation (Regions 1 and 6) are observed
at a DNA level, however, Region 6 is only partially present in the Japanese strain
and is also inverted in comparison to the NZ strain. The absent portion of Region 6
consists of two putative genes.
The NZ strain was also compared with the Korean strain and P.s pv. theae. This
revealed the conservation of Region 1 and the whole of Region 6 (Figure 3.2). Note,
Region 6 in the Korean strain and P.s pv. theae are in the same orientation as the
NZ strain rather than inverted as in the Japanese genome. Like the Japanese genome,
Regions 2-5 are absent. Instead, approximately 11 kb of sequence separates Region 1
and Region 6 in the draft genome of P.s pv. theae. Similarly, the Korean strain has
26 kb of sequence separating Region 1 and Region 6 (Figure 3.2). Of course, with the
absence of Region 2, these strains also lack the NZ type I RM system, Psy18884I.
The NZ strain was also compared with the Chinese strain M228. The Chinese strain
lacks Region 2 but has the flanking homologous Regions 1 and 6. Regions 3-5 are
also present in M228 but are rearranged into other areas of the genome (Figure 3.2).
Another type I RM system is identified in Region three, shared by the New Zealand
and Chinese strains. However, the version found in the NZ genome is likely to be
defective due to an IS element, ISPsy34, disrupting the putative DNA methylase
gene. This disrupted DNA methyltransferase gene begins at 33,116 bp. This is in
line with the PacBio sequencing data only recognising one type I RM system (the
one found in Region 2). Comparatively, the homologue found in the Chinese strain
is intact and predicted to be functional. It is suggested that this type I RM system
corresponds to the recognised type I methylation site, GAYCN5CTGC, in the PacBio
sequencing data of the Chinese strain (Table 3.1).
Through these comparisons, it is hypothesised that Regions 2-5 were acquired in two
separate events. In the temporal sense, the first acquisition was of Regions 3-6. It
is evident that this acquisition in M228 has rearranged within the genome compared
to the NZ genome, where the segment has remained together. This first acquisition
appears to have brought in a type I RM system. This type I system has since become
non-functional in the NZ genome. However, the RM system is predicted to be active
in the Chinese strain corresponding to the GAYCN5CTGC type I motif seen in the
PacBio methylation profile. It is also apparent the second acquisition (Region 2),
carrying Psy18884I, occurred only in the progenitor of the NZ strain with no sequence






























































































































































































































































































































































































































Type II RM system
In addition to containing a type I RM system, the NZ strain is also predicted to
contain an active type II RM system termed Psy18884II which recognises CTCGAG
(Templeton et al., 2015). The corresponding DNA methyltransferase gene begins at
183,182 bp. The system is encoded by the ORFs NZ708 00855 and NZ708 00865,
a DNA methyltransferase and putative restriction endonuclease, respectively. This
type II RM system is embedded in a 20,572 bp region absent from the Japanese
strain (Figure 3.3).
This region of the NZ genome was also compared with the P.s pv. theae draft genome.
Majority of the region is intact, including genes encoding the type II RM system. The
presence of these genes in P.s pv. theae corresponds to its PacBio sequencing data
recognising the CTCGAG type II motif. This motif is also recognised by the NZ
strain.
In terms of the Chinese genome, the 20 kb region has a 99% identity match to the
same region found in the NZ strain. Further, the ORFs predicted to encode for the
type II system has an 100% identity match. Despite this, the M228 type II RM system
is apparently non-functional with the methylome data not recognising a type II RM
system motif. It is not obvious why this is the case. One possible explanation for
the apparent mismatch in function and genetic sequence could be the addition of a 5
kb insertion found upstream in the Chinese genome (indicated by a black triangle in
Figure 3.3).
The majority of the 20 kb region is present within the Korean Psa strain, but it is
apparent that several genes have been lost. This includes genes encoding the type II
RM system. The presence of the region in four out of five strains analysed, including
P.s pv. theae, suggests that this region has been lost from the Japanese strain.
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Figure 3.3: Comparison of putative type II RM system in New Zealand ICMP 18708
with other Pseudomonas
Psa strains isolated from various countries were compared against a 27,463 kb region
in the New Zealand pandemic Psa strain ICMP 18708. P.s pv. theae ICMP 3923
was also compared. ⇠20 kb is absent from the Japanese genome. A type II RM
system is predicted to be embedded in this region. Homologous sequences are a
minimum 98% identity match. Gene annotations have not yet been completed for the
Korean Psa strain K4 and P.s pv. theae ICMP 3923 genomes.
Other predicted RM systems and putative dcm methylase
Based on sequence similarity, REBASE has also predicted other putative RM systems
in the NZ Psa strain, including two type II RM systems and one type III RM system.
However, these are expected to be non-functional due to the absence of corresponding
methylation motifs.
One of the putative type II RM systems (beginning at 1,104,993 bp) has two minia-
ture inverted-repeat transposable elements (MITE) interrupting the annotated DNA
methyltransferase/restriction endonuclease fusion gene. The same scenario is observed
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in the Chinese strain. The two MITEs are located directly adjacent to one another
and are identical except for an A/C substitution. In fact, the MITE with an A
substitution is only found once in the NZ chromosome whereas the MITE with a C
substitution is found sixty-eight times. Similarly, the MITE with an A substitution is
only found twice in the Chinese chromosome compared to the MITE with a C substi-
tution which is found forty-nine times. Conversely, this gene (along with the inserted
MITES) is completely absent in P.s pv. theae. The gene is partially present in the
Korean strain, however only at a 93% identity match. A homologue of this gene is
also found within the Japanese genome, however, MITEs have not interrupted the
gene. Both versions of MITEs cannot be found within the Japanese, Korean or P.s
pv. theae genome. The homologue present in the Japanese genome is also predicted
to be inactive as it appears to be severely truncated.
The other type II RM system predicted by REBASE begins at 5,495,131 bp in the
NZ strain. The putative DNA methyltransferase resides within Pac ICE1, however,
a cognate restriction endonuclease is absent. This solitary DNA methyltransferase
is unseen in the other Pseudomonas strains analysed. This putative DNA methyl-
transferase is likely a DNA cytosine methyltransferase (dcm) which is required for
DNA repair rather than methylation of restriction sites. BLAST search results of
the protein sequence against the NCBI protein database reveal the presence of a dcm
methylase conserved domain.
The putative type III RM system in the NZ strain also contains two identical MITES
disrupting the predicted DNA methyltransferase. This disrupted DNA methyltrans-
ferase gene begins at 1,838,271 bp in the NZ genome. Interestingly, M228 only contains
one MITE. In the Japanese and Korean Psa genome, the DNA methylase is separated
by genome rearrangements and can be found in two halves. This is also the case
within the P.s pv. theae genome.
3.1.2 Japanese Psa strain ICMP 9853
The Japanese Psa strain ICMP 9853 belongs to Biovar 1 and is one of the earliest Psa
isolates obtained (Takikawa et al., 1989). It is evident the Japanese strain contains a
unique set of RM systems as indicated by the PacBio methylation profile (Table 3.1).
All positions are related to the sequence of ICMP 9853 in GenBank (accession num-
ber of main chromosome is CP018202). The Japanese genome contains a functional
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type II system and type III system, recognising the motifs CTGCAG and TCCACC,
respectively. There are also several non-functional systems observed. All predicted
RM systems are represented in Figure 3.4.
Figure 3.4: RM systems found in the Japanese Psa strain ICMP 9853
Proven and predicted potential RM systems in the Japanese genome are presented. A
white circle indicates those that are non-functional. Adapted from figures produced
by REBASE (Roberts et al., 2014).
Type II RM system
The type II RM system of the Japanese genome is termed Psy9853I. Genes predicted
to encode the putative restriction endonuclease and DNA methyltransferase are found
at ORFs JN853 08430 and JN853 08435, respectively. The DNA methyltransferase
gene begins at 1,704,452 bp. The RM system and the surrounding ⇠16 kb of sequence
is absent from the Korean, Chinese and NZ Psa strains analysed. It is also absent
in P.s pv. theae. Gene annotations in this island include a chromosome partitioning
protein gene and P-type conjugative transfer protein gene, suggesting this island are
remnants of a conjugative element such as a plasmid or ICE element. This region also
contains many highly repetitious sequences.
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Type III RM system
The Japanese type III RM system, termed Psy9853II, is also absent from other Psa
strains. The ORFs JN853 28820 and JN853 28825 are predicted to encode the two
components that make up the type III RM system. The DNA methyltransferase
gene begins at 6,024,961 bp. Many genes adjacent to this type III RM system are
associated with phages, therefore it is hypothesised this RM system was introduced
into the Japanese strain via transduction. The NZ Psa, Chinese Psa and P.s pv.
theae do not carry this type III RM system nor the adjacent phage-associated genes.
Conversely, the Korean strain has some similarities to the adjacent phage-associated
genes but lacks the type III RM system.
Other predicted RM systems and putative dam methylase
In addition to two functional RM systems, the Japanese strain is predicted to contain
a non-functional type II RM system with the gene beginning at 5,320,339 bp. It is
predicted to be inactive as it is severely truncated. A homologue of this gene can be
found within the New Zealand and Chinese genome where it is also inactive due to
the disruption by inserted MITES.
An methyltransferase gene without a cognate restriction endonuclease gene can also
be observed in the Japanese genome beginning at 6,033,170 bp. A BLAST search of
the protein sequence against the NCBI protein database revealed the presence of a
DNA adenine methylase (dam) conserved domain. This ORF is found in the context
of phage associated genes in the vicinity of the type III RM system, Psy9853II.
3.1.3 Chinese Psa strain M228
The Chinese Psa strain M228 belongs to Psa Biovar 3. The PacBio sequencing results
reveal an active type I system in the Chinese Psa strain M228 recognising the motif
GAYCN5CTGC (Table 3.1). This RM system is predicted to reside in Region 3
(Figure 3.2) with the DNA methyltransferase gene beginning at 6,582 bp. Numbering
begins at the origin of replication.
Through sequencing analysis, the Chinese strain is also predicted to carry a type
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II RM system with the DNA methyltransferase gene beginning at 6,274,983 bp. It
is observed to harbour genes homologous to genes encoding an active type II RM
system found within P.s pv. theae and the NZ Psa strain (Figure 3.3). However,
PacBio sequencing methylation data do not reflect the presence of an active type II
RM system.
Similar to the NZ genome, the Chinese genome is predicted to contain a type II and
type III RM system. However, both RM systems have been disrupted by MITES,
which is also the case in the NZ genome. The corresponding DNA methyltransferase
of the disrupted type II and type III systems begin at 924,688 bp and 4,788,939 bp,
respectively, in the Chinese genome.
3.1.4 P.s pv. theae ICMP 3923
The results of the Pacbio sequencing analysis suggest P.s pv. theae ICMP 3923 holds
a large repertoire of RM systems, including two type I, one type II and one type III
RM system (Table 3.1). Of particular interest is the type II RM system as it shares
the same recognition site CTCGAG and corresponding genes as the NZ strain ICMP
18708. Through comparative genomics, it was shown that the putative genes encoding
the type II RM system in the NZ strain and observed in the Chinese strain, are also
present in P.s pv. theae ICMP 3923 (Figure 3.3).
3.1.5 Korean Psa strain K4
The Korean Psa strain K4 falls within Psa Biovar 2. From the PacBio sequencing
analysis, the Korean strain recognises a non-palindromic sequence GATCGAG (Table
3.1). Methylation of this motif is predicted to be made by a unique type III RM
system or type IIG RM system. P. stutzeri 273 also recognises GATCGAG and is
annotated as a type IIG RM system (Wu et al., 2017). However, P. stutzeri 273 type
IIG RM system does not have significant protein or DNA similarity when compared
with the Korean Psa genome.
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3.2 E↵orts to introduce the CRISPR/Cas9 system
into Psa strain ICMP 18708 via conjugation
The aim of these experiments was to transfer the pMZ3 plasmid containing elements
of the CRISPR/Cas9 system into the recipient strain ICMP 18708, an early New
Zealand Psa isolate. The method of conjugative transfer was employed to mobilise the
CRISPR/Cas9 plasmid into Psa. This is based on the assumption that this method
may provide more protection for the plasmid from the hypothesised RM systems of
Psa compared to electroporation. The donor strain used was E. coli S17-1 which
contains full conjugative capability.
3.2.1 Cloning origin of transfer sequence into pMZ3 plamsid
To produce a conjugative pMZ3 plasmid, it was necessary to clone an origin of transfer
(oriT) sequence into the plasmid. This was achieved by a two step cloning process.
Firstly, the ↵ peptide coding region was inserted into the pMZ3 plasmid to give blue
colonies. The second step replaced the ↵ peptide coding region with the oriT sequence
allowing selection of white colonies. This two step cloning process was carried out
rather than directly cloning the oriT sequence into pMZ3 due to the di culty of no
selection of the latter method.
The cloning of the ↵ peptide encoding region into pMZ3 can be seen in Figure 3.5.
The sequence was successfully amplified from the pGEM-t easy plasmid with specific
primers containing synthetic XbaI sites (Figure 3.5). AflII and XhoI sites were also
added to forward and reverse primers interior to the XbaI sites, respectively. These
restriction sites were required in downstream steps.
The pMZ3 plasmid with the ↵ peptide coding sequence was transformed into compe-
tent E. coli DH5↵ to be propagated. Plasmids were isolated from four blue colonies
and analysed with a double restriction digest (AflII and XhoI) (Figure 3.5). Analysis
of plasmids 2-4 show two bands; 9 kb and 1 kb which were the predicted lengths of the
pMZ3 plasmid and ↵ peptide encoding region, respectively. The result suggests that
plasmids 2-4 had successfully incorporated the ↵ peptide encoding region into pMZ3
plasmid. The resulting plasmid will be referred to as pMZ3+↵pep. Plasmid 1 remained
unchanged after digestion. This suggests the AflII and XhoI restrictions sites were
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not present. Furthermore, plasmid 1 was considerably smaller than the expected 9 kb
pMZ3 plasmid and was likely to be a pGEM-t easy plasmid contaminant.
Figure 3.5: Cloning ↵ peptide encoding region into pMZ3 plasmid
Using specific primers (represented by blue arrows), the ↵ peptide encoding region
was amplified from the pGEM-t easy plasmid. The PCR product was digested with
XbaI and ligated into the insertion XbaI site of pMZ3. The ligation was transformed
into E. coli DH5↵. Plasmids were isolated from blue colonies and subjected to a
double restriction digest (AflII and Xhol).
pMZ3+↵pep was digested with AflII and XhoI to remove the ↵ peptide encoding re-
gion and allow the ligation of the oriT sequence in its place (Figure 3.6). The oriT
sequence was amplified from the pEX18Gm plasmid with specific primers with syn-
thetic AflII and XhoI sites at the 5’ ends. The resulting plasmid was transformed
into E. coli DH5↵ and white colonies were selected. A low frequency of transfor-
mation was observed, therefore, a colony PCR was completed on all colonies (Figure
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3.6). The oriT sequence was amplified with specific primers. A band approximately
1.3 kb was observed for the colony three sample. This was the expected length of
the oriT sequence. The plasmid was isolated from colony 3 and a double restriction
digest analysis with AflII and XhoI restriction enzymes was completed (Figure 3.6).
A band of an expected 1.3 kb length was observed. This suggests the oriT sequence
was successfully incorporated into the pMZ3 plasmid and will be called pMZ3+oriT.
Figure 3.6: Cloning origin of transfer sequence into pMZ3
Using specific primers (represented by blue arrows), the oriT sequence was amplified
from the pEX18Gm plasmid. The PCR product was digested with AflII and Xhol
and ligated into the corresponding insertion site of pMZ3. The ligation was
transformed into E. coli DH5↵. A colony PCR was completed to identify colonies
containing the oriT sequence. A plasmid isolation was completed from colony 3 and
then subjected to a double restriction digest (AflII and Xhol).
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For the following conjugation experiments, it was desirable to make pUCP22 con-
jugative to have an appropriate positive control. Since pUCP22 already contains an
↵ peptide encoding region, the cloning of the oriT sequence into pUCP22 was se-
lectable with the disruption of LacZ function. The oriT sequence was amplified from
the pEX18Gm plasmid with specific primers containing synthetic SpeI sites at the
5’ ends. These are compatible with the XbaI site located in the ↵ peptide encoding
region of the pUCP22 plasmid. The resulting plasmid was successfully transformed
and isolated from E. coli DH5↵ and will be referred to as pUCP22+oriT (Figure 3.7).
This plasmid already harbours two origins of replication allowing for replication in E.
coli and Pseudomonas. With the addition of an oriT, it allows pUCP22 to transfer
via conjugation in a range of bacteria.
(a) Colony crack PCR (b) Plasmid isolation
Figure 3.7: Cloning of the oriT sequence into pUCP22 plasmid
Transformants were interrogated with primers specific to the oriT sequence in a
colony PCR. Plasmids were subsequently isolated from colonies that were positive.
3.2.2 Electroporation of pMZ3+oriT into E. coli S17-1
The pMZ3+oriT plasmid was introduced into E. coli S17-1 through electroporation.
This E. coli strain carries the genetic components required for conjugation. Ampicillin
resistant E. coli S17-1 colonies were selected and subsequently tested with a colony
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PCR for the presence of the pMZ3+oriT plasmid (Figure 3.8). The PCR primers
(Table 2.5) correspond to sequence within the oriT sequence and should yield a ⇠1.3
kb PCR product. However, multiple bands were observed for some of the samples,
with the brightest band perceived at approximately 1.5 kb. To clarify this, plasmids
were isolated from four colonies: 1,6,7 and 8. A double restriction digest with XhoI
and AflII was completed to deduce if the correct plasmid was transferred into E. coli
S17-1 (Figure 3.8a). The plasmid isolated from colony 6 displayed the correct size
bands of 9 kb and 1.3 kb. Plasmid 8 also displayed very faint bands of the appropriate
size (Figure 3.8b). To further validate this, plasmid 6 was sequenced with primers
external to the oriT sequence (Appendix 5.2). The results showed that it was the
correct pMZ3+oriT plasmid.
(a) Colony crack PCR (b) Plasmid isolation and double re-
striction digest
Figure 3.8: Identification and isolation of pMZ3+oriT from E. coli S17-1
The E. coli S17-1 transformants were interrogated with primers specific to the oriT
sequence with a colony PCR. However, this was inconclusive with multiple bands
observed. Therefore, a plasmid isolation was completed from four colonies (1,6,7 and
8). A double restriction digest with AflII and Xhol was carried out. It was expected
to yield two bands at approximately 9 kb and 1.3 kb. This was observed for plasmid 6
and plasmid 8.
Similarly, pUCP22+oriT was successfully electroporated into E. coli S17-1 (Figure 3.9).
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This was verified with a colony PCR with primers specific to the oriT sequence.
Figure 3.9: Colony crack PCR of E. coli S17-1 electroporated with pUCP22+oriT
The E. coli S17-1 transformants were interrogated with primers specific to the oriT
sequence to identify colonies that successfully accepted the pUCP22+oriT plasmid.
3.2.3 Conjugation of pMZ3+oriT into Psa ICMP 18708
With the pMZ3+oriT plasmid successfully introduced into E. coli S17-1, a conjugation
was attempted to transfer the plasmid into the recipient Psa strain ICMP 18708. If
successfully transferred, the transconjugants will be selectable with both ticarcillin
and cefotaxime. Ticarcillin resistance is encoded on the pMZ3+oriT plasmid, whilst
Psa is inherently cefotaxime resistant.
To ensure the conjugative system of E. coli S17-1 can indeed transfer the pMZ3+oriT
plasmid, a mating was also set up with E. coli DH5↵ as the recipient. E. coli DH5↵
allows the replication of pMZ3. The pET24(+) plasmid encoding kanamycin resis-
tance was also introduced into E. coli DH5↵ allowing selection of the recipient. The
pET24(+) plasmid does not contain an oriT sequence, therefore, cannot be transferred
during the conjugation process. E. coli transconjugants would be both ampicillin and
kanamycin resistant as they will carry the pMZ3+oriT and pET24(+) plasmids.
Another control was set up to ensure Psa ICMP 18708 can successfully participate in
a conjugative mating with E. coli S17-1. To do this, the conjugation of the control
plasmid, pUCP22+oriT, was attempted from E. coli S17-1 to Psa and E. coli DH5↵.
The number of transconjugants for the conjugation experiments can be seen in Table
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3.2. The conjugation of pMZ3+oriT and pUCP22+oriT into E. coli DH5↵ gave a cell
count of 1x104 cfu/ml and 2x104 cfu/ml, respectively. The transfer of the pMZ3+oriT
plasmid was confirmed with a colony PCR (Figure 3.10a). This was further validated
through the sequencing of a plasmid isolated from E. coli DH5↵ (isolated from Colony
2) (Appendix 5.3). 2x105 cfu/ml growth of pUCP22+oriT ICMP 18708 transconjugants
were observed. A colony PCR was completed to show that the correct plasmid had
been transferred (Figure 3.10b). Conjugation of pMZ3+oriT into ICMP 18708 was
unsuccessful.
Table 3.2: Number of transconjugants
Psa ICMP 18708 E. coli DH5↵1
(cfu/ml) (cfu/ml)
pMZ3+oriT - 1x104
pUCP22+oriT 1 2x105 2x104
1Control
(a) E. coli DH5↵ pMZ3+oriT
transconjugants
(b) Psa ICMP 18708
pUCP22+oriT transconjugants
Figure 3.10: Colony PCR of transconjugants
E. coli DH5↵ and Psa ICMP 18708 transconjugants were interrogated with primers
specific to the oriT sequence. This allowed the identification of pMZ3+oriT and
pUCP22+oriT plasmids that had successfully transferred through conjugation.
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In summary, these experiments demonstrated that the plasmid pUCP22+oriT can ef-
fectively transfer by conjugation into both Psa ICMP 18708 and E. coli DH5↵. The
CRISPR/Cas plasmid, pMZ3+oriT, also successfully transferred by conjugation into E.
coli DH5↵. However, the critical step of transferring the pMZ3+oriT into Psa ICMP
18708 failed. Alternatively, the pMZ3+oriT plasmid may have transferred into Psa but
has failed to replicate.
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3.3 E↵orts to introduce the CRISPR/Cas9 system
into Psa strain M228 via electroporation
Previous experiments to introduce the CRISPR/Cas9 plasmid, pMZ2, into Psa strain
ICMP 18708 via electroporation have been unsuccessful (Zhao, 2015). It was initially
proposed that this was due to the recognition of type I restriction sites in the plasmid
by Psa ICMP 18708. Alteration of these sites resulted in the plasmid pMZ3. However,
transformation of pMZ3 still yielded low transformation numbers in Psa (Zhao, 2016).
Only one type I restriction site recognised by ICMP 18708 remain in pMZ3. This is
located in the ampicillin resistance gene.
Informed by previous experiments conducted by Zhao and the in silico analysis of
various Psa strains, it was concluded that the Chinese Psa strain M228 might be a
more appropriate recipient for the pMZ3 plasmid compared to the New Zealand strain
ICMP 18708. The identified restriction target sites of M228 are not present in the
pMZ3 plasmid (Table 3.3).
Table 3.3: Known restriction recognition sites of di↵erent Pseudomonas present in
utilised plasmids
Strain RM system Recognition pMZ3 pMZ4 pUCP22
type site
Psa ICMP I AGCAN5GTC 1 0 2
18708 II CTCGAG 0 0 0
Psa M228 I GAYC5CTGC 0 0 0
Psa K4 III/IIG GATCGAG 1 1 1
P.s pv. theae I AGGN4CCT 2 2 0
ICMP 3923 I TCCAN6CAT 1 1 0
II CTCGAG 0 0 0
III GAAGAT 16 14 5
An attempt was made to transform pMZ3 into M228 and ICMP 18708 via electro-
poration with pUCP22 as a positive control. Based on ticarcillin/ampicillin resistant
colony counts, the e ciency of transformation for pMZ3 and pUCP22 into M228 were
5.41x102 cfu/µg DNA and 3.39x107 cfu/µg DNA, respectively (Table 3.4). The trans-
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formation of pMZ3 into M228 was more e cient compared to the transformation of
the same plasmid into ICMP 18708 (Table 3.4). The transformation of pMZ3 into
ICMP 18708 was not successful. This supported the result of previous experiments
where low frequency of transformation was also observed.
Table 3.4: Transformation e ciencies of the transfer of pMZ3 to ICMP 18708 and
M228




The colonies of M228 were tested on King’s B gentamicin to ensure the colonies ob-
served were not due to pUCP22 contamination (pUCP22 also encodes for gentamicin
resistance). Twenty-three out of twenty-nine colonies tested negative for gentamicin
resistance. A colony PCR was utilised to test whether the Cas9 encoding gene was
present in these colonies. Several di↵erent primers were trialled, however, results were
inconclusive. Plasmid isolations were completed (Figure 3.11). This resulted in di↵er-
ent plasmid sizes compared to the stock pMZ3 plasmid and from each other. Plasmid
1 and 18 were sequenced with primers specific to the Cas9 encoding gene (Appendix
5.4). Sequencing revealed portions of the pMZ3 plasmid were absent (Figure 3.12).
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Figure 3.11: Plasmid isolations of M228 transformants electroporated with the pMZ3
plasmid
(a) pMZ3 (1) (b) pMZ3 (18)
Figure 3.12: Regions lost in pMZ3 plasmids isolated from M228
Using various primers, the Cas9 gene was sequenced. It revealed positions 2,426 -
7,012 bp and 2,203 - 3,831 bp were absent from plasmid 1 and 18, respectively. This
is highlighted in red. Figure created on Geneious 10.1.3 (Kearse et al., 2012).
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3.4 Restriction alleviation
It was assumed that the deletion of sequence within pMZ3 was likely due to the
action of restriction systems. To overcome the proposed barrier of Psa RM systems,
restriction alleviation was explored. Restriction alleviation (RA) is a phenomenon
that occurs when DNA is damaged from exposure to chemicals such as nalidixic acid
(Thoms & Wackernagel, 1984). It is speculated to cause unmodified restriction sites
in the host genome (Thoms & Wackernagel, 1984). As a result, the RM systems in
the bacteria are temporarily disabled to prevent autoimmunity. Like nalidixic acid,
ciprofloxacin is a quinolone with a similar mode of action (Phillips et al., 1987). RA
generated by ciprofloxacin was explored as a method of evading the hypothesised RM
system in Psa to allow for the successful transfer of the CRISPR/Cas9 plasmid.
Firstly, a concentration of ciprofloxacin was determined which inhibited growth of
Psa but did not prove lethal. This was completed by inoculating 100 mL of Luria
broth with Psa and grown overnight at 28  C at approximately 250 RPM. When the
culture was estimated to be at log phase, it was split into 10 ml aliquots where di↵erent
concentrations of ciprofloxacin were added. Log phase was determined through OD600
readings taken at 1 - 2 hour intervals. After two hours of ciprofloxacin exposure, the
cells were plated on King’s B medium to check for cell viability.
The first range of ciprofloxacin concentrations tested were between 1 - 100 µg/ml
(Figure 3.13a). At these concentrations, cells were no longer viable with no growth
observed when plated. The second range of concentrations trialled was lower, between
0.1 - 1 µg/ml (Figure 3.13b). The ideal concentration of ciprofloxacin was found to
be 0.1 µg/ml final concentration where growth rates were lowered but bacteria still
showed viability. Growth was approximately 1x105 cfu/ml compared to the control
of 2x105 cfu/ml.
Once the appropriate concentration of ciprofloxacin was obtained, it was trialled to
see if it a↵ected the transformation e ciency of the pMZ3 plasmid in ICMP 18708
and M228 Psa strains. Two hours prior to the sucrose washing steps in the electro-
poration protocol, ciprofloxacin was added to 100 ml of Psa culture to give a final
concentration of 0.1 µg/ml. No substantial di↵erences were observed between trans-
formations with and without ciprofloxacin (Table 3.5). This was not explored further
as it was concluded that whatever the issue was with the transformation of the pMZ3
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plasmid, it could not be overcome by RA.
(a)
(b)
Figure 3.13: Growth of Psa with di↵erent concentrations of ciprofloxacin
OD
600
readings were taken over the growth course of Psa. Di↵erent concentrations
of ciprofloxacin were added at the time point indicated by the red arrow.
Table 3.5: Number of ticarcillin/ampicillin resistant Psa colonies
Ciprofloxacin +/- Psa ICMP 18708 (cfu/ml) M228 (cfu/ml)
pMZ3 + 0 1x101
pMZ3 - 0 1x101
pUCP221 + 9x103 4.9x105
pUCP221 - 1.8x104 9.6x105
1Control
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Modification of the CRISPR/Cas9 plasmid
The next three sections describe the alterations made to the CRISPR/Cas9 plasmid
in an attempt to successfully transfer the plasmid into Psa. The transformation
e ciencies of the pMZ plasmid derivatives were calculated based on the relevant
antibiotic resistant colony counts. This is shown in Table 3.6. Eventually, transfer of
the CRISPR/Cas plasmid with all elements were achieved in Section 3.7.4.
Table 3.6: Summary of transformation e ciencies of various plasmids into di↵erent
strains
ICMP 18708 M228 K4 P.s pv. theae
(cfu/µg DNA) (cfu/µg DNA) (cfu/µg DNA) (cfu/µg DNA)
pMZ3 0 5.41x102 N/A N/A
pMZ4 6.39x102 9.35x101 0 0
pMZ44Ndel 1.30x105 7.09x103 N/A N/A
pMZ44BamHI 0 1.48x103 N/A N/A
pUCP22+NdeI 2.55x103 1.64x107 N/A N/A
pMZ5 3.75x102 7.14x101 N/A N/A
pUCP221 1.76x105 3.39x107 2.97x104 4.43x105
1Positive control
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3.5 Modification of the CRISPR/Cas9 plasmid from
ampicillin to kanamycin selection
A type I restriction site recognised by ICMP 18708 (AGCAN5GTC) was identified
in the ampicillin resistance gene of pMZ3 (Table 3.3). It was hypothesised that this
may be preventing transformation of pMZ3 into ICMP 18708. To rectify this, the
ampicillin resistance gene was replaced with a kanamycin resistance gene which does
not contain known restriction sites of ICMP 18708 or M228.
3.5.1 pMZ3 to pMZ4 (ampicillin to kanamycin selection)
To allow the insertion of the kanamycin resistance gene in place of the ampicillin gene,
a restriction digest was completed using XbaI and ClaI. This removed the ampicillin
gene from the pMZ3 plasmid. The kanamycin gene was amplified from the pET24(+)
plasmid using specific primers with synthetic restriction sites, XbaI and Nar I, at the
5’ end of the forward and reverse primers, respectively. Nar I sites are compatible with
ClaI sites. The kanamycin PCR product was ligated into the XbaI/ClaI sites of pMZ3
and propagated in E .coli DH5↵. A plasmid isolation was completed and was run on a
gel. It was observed to be comparable in size to the original pMZ3 plasmid which was
expected. It was sequenced with primers specific to the kanamycin resistance gene.
Results showed the kanamycin resistance gene had successfully replaced the ampicillin
resistance gene in pMZ3 (Appendix 5.5). The resulting plasmid will be referred to as
‘pMZ4’.
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Figure 3.14: Cloning of the kanymacin resistance gene into pMZ3 plasmid
Using specific primers (blue arrows), the kanamycin encoding gene was amplified
from the pET24(+) plasmid. The PCR product was digested with XbaI and NarI and
ligated into the insertion XbaI/ClaI site of pMZ3. The ligation was transformed into
E. coli DH5↵. Resulting colonies were selected for with kanamycin. A plasmid
isolation was completed.
3.5.2 Electroporation of pMZ4 into various Psa strains and
P.s pv. theae
The new pMZ plasmid derivative, pMZ4, was introduced into Psa strains ICMP 18708
(NZ), M228 (China), K4 (Korean) and P.s pv. theae ICMP 3923 via electroporation.
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pUCP22 was also electroporated as a positive control. The e ciency of transformation
can be seen in Table 3.6. The electroporation of K4 and P.s pv. theae elicited no
transformants. This was unsurprising given the RM systems they harbour recognises
restriction motifs found in the pMZ4 plasmid (Table 3.3). The transformation of pMZ4
into ICMP 18708 yielded an e ciency of 6.39x102 cfu/µg DNA, a great improvement
from the transformation of pMZ3 (Table 3.6). The electroporation of M228 with pMZ4
was also successful, yielding a transformation e ciency of 9.35x101 cfu/µg DNA.
Plasmid isolations were completed for both M228 and ICMP 18708 transformants
(Figure 3.15). They were subsequently sequenced with primers specific to the Cas9
encoding gene (Appendix 5.6). This revealed substantial deletions in the plasmids iso-
lated from both ICMP 18708 and M228 (Figure 3.16). All deletions included a portion
of the Cas9 encoding region, however, the deletions di↵ered in size and position.
Figure 3.15: Plasmid isolations of M228 and ICMP 18708 transformants electropo-
rated with pMZ4 plasmid
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(a) pMZ4 (4) from ICMP 18708 (b) pMZ4 (8) from ICMP 18708
(c) pMZ4 (1) from M228 (d) pMZ4 (8) from M228
Figure 3.16: Regions lost in the pMZ4 plasmid isolated from ICMP 18708 and M228
Using various primers, the Cas9 gene was sequenced. It revealed gaps missing from
plasmids isolated from ICMP 18708. Specifically, positions 1,808 - 4,660 bp and
2,342 - 7,427 bp were absent from plasmid 4 and 8, respectively. Similarly, positions
1,676 - 4,482 bp and 2,556 - 6,906 bp were absent from plasmid 1 and 8 isolated
from M228. This is highlighted in red. Figure created on Geneious 10.1.3 (Kearse et
al., 2012).
Although transformation e ciency increased in ICMP 18708 and remained similar in
M228, the pMZ4 plasmid was still unable to remain unaltered in Psa. It was theorised
this result was due to the continued activity of the Psa RM systems.
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3.6 Modification of the CRISPR/Cas9 plasmid to
remove possible non-canonical restriction sites
The electroporation experiments thus far revealed that an intact pMZ4 plasmid can-
not be successfully isolated from the Psa strains tested. It was proposed that the
hypothetical RM systems from ICMP 18708 and M228 were continuing to recognise
a target sequence within the CRISPR-Cas9 plasmid. The in silico analysis suggests
that there are only two active RM systems in ICMP 18708 and one active RM sys-
tem in M228. Using this knowledge, all known recognition sites in the CRISPR/cas9
plasmid have been resolved. One possibility involves the recognition of non-canonical
restriction sites by known RM systems. Of particular focus were type I restriction
sites. Plasmids that were isolated had di↵ering deletion sizes, suggesting the deletions
were not caused by a type II RM system. Type II RM systems are expected to cause
more uniform deletions due to the mechanism of cleavage. Using Geneious, Type I
restriction recognition sequences with a single base mismatch were identified in the
pMZ4 plasmid (Figure 3.17).
Of particular interest are those that fall within the Cas9 endonuclease encoding gene.
Other components of the CRISPR/Cas9 plasmid, such as the Pseudomonas and E.
coli origin of replication and kanamycin resistance gene does not appear to be a↵ected
by the hypothesised RM systems of Psa. Base changes of the underlined guanine
nucleotide of the ICMP 18708 type I restriction site (AGCAN5GTC) were not found
outside of the Cas9 encoding region (Figure 3.17a). Similarly, base changes to the
pyrimidine (Y) nucleotide of the M228 type I restriction site (GAYCN5CTGC) were
found in two occurrences within the Cas9 encoding gene (Figure 3.17b). These are





Figure 3.17: Single base mismatch of type I restriction sites from ICMP 18708 and
M228 identified in the pMZ4 plasmid
Type I restriction sites from ICMP 18708 and M228 with a single base di↵erence
were identified in the pMZ4 plasmid. The base di↵erences were noted down in
correspondence with the canonical restriction recognition site. The sites highlighted
in orange fall within the Cas9 endonuclease encoding gene. The bases highlighted in
yellow represent those that are methylated by the methyltransferase component of the
RM system. Note the base changes enclosed in a black box may be of significance.
3.6.1 pMZ44Ndel
To explore the idea of whether non-canonical restriction sites were behind the issues
that arose during the introduction of the CRISPR/Cas9 plasmid into Psa, pMZ4
was modified to remove a majority of the non-canonical restriction sites deemed of
significance. These were identified to be the guanine base di↵erences of the ICMP
18708 type I restriction site that occurred in the Cas9 encoding gene (Figure 3.17a).
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An NdeI-NdeI fragment (1.4 kb in length) removed 4/5 of these sites. This deletion
also reduced the amount of S. pyogenes derived sequence in the plasmid. The NdeI
restriction sites are found at positions 2,897 bp and 4,332 bp of the pMZ4 plasmid.
ScaI was added in conjunction with NdeI to cleave the original NdeI fragment and
prevent the formation of the parental plasmid. To confirm if the fragment was removed
successfully, a restriction digest with NdeI was completed where a single band was
expected as a result (Figure 3.18). Plasmids 6 and 7 were observed with just one band
after the NdeI digestion suggesting the fragment had been successfully removed. This
was further validated through sequencing (Appendix 5.7). The final plasmid will be
called ‘pMZ44Ndel’.
Figure 3.18: Restriction digest (NdeI) of isolated pMZ44Ndel
A restriction digest with NdeI was completed on the isolated plasmids to ensure the
plasmid had successfully self ligated. Also seen are undigested and digested versions
of the control plasmid, pMZ4.
3.6.2 Electroporation of pMZ44Ndel into Psa strains ICMP
18708 and M228
pMZ44Ndel was electroporated into ICMP 18708 and M228 with a transformation
e ciency of 1.30x105 cfu/µg DNA and 7.09x103 cfu/µg DNA, respectively (Table 3.6).
Plasmids were isolated from the transformants (Figure 3.19), two from each strain,
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and sequenced (Appendix 5.8). Interestingly, all plasmids sequenced had an identical
fragment missing, ranging from 2,121 - 5,270 bp (Figure 3.20). The regions flanking
the deletion consisted of the direct repeats found in the tracrRNA and CRISPR array.
Figure 3.19: Plasmid isolations from M228 and ICMP 18708 transformants electro-
porated with pMZ44Ndel plasmid
Figure 3.20: Region lost in the pMZ44Ndel plasmids isolated from ICMP 18708 and
M228
Using various primers, the Cas9 gene was sequenced. The red indicates the region
2,121 - 5,270 bp had been lost. Of the four di↵erent plasmids sequenced, the same
deletion was observed. Figure created on Geneious 10.1.3 (Kearse et al., 2012).
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In conclusion, the transformation of pMZ44Ndel provided a much higher frequency
of transformats (Table 3.6). This was believed to be either due to the removal of
ICMP 18708 non-canonical restriction sites or the disruption the CRISPR/Cas9 sys-
tem. Nevertheless, analysis of the plasmids isolated from multiple transformants
revealed the plasmids had undergone recombination which eliminated almost all of
the CRISPR/Cas9 system from pMZ44Ndel.
3.6.3 pMZ44BamHI
To explore the incompatibility observed in the pMZ4 plasmid and its derivative, an-
other fragment was removed and transformed into Psa. This incompatibility was
believed to be either due to non-canonical restriction sites or the toxicity of the
CRISPR/Cas9 system. Using the restriction enzyme BamHI, a 1.3 kb portion be-
tween positions 5,796 bp and 7,145 bp of the pMZ4 was removed. SacI was used in
conjunction to prevent the re-ligation of the fragment back into the plasmid. This
removed the crRNA, a component required to guide the Cas9 endonuclease to the
target sequence for cleavage. It also removed a portion of the Cas9 endonuclease
which also included the non-canonical restriction sites of M228 considered of interest
(Figure 3.17b). To confirm the fragment had been removed successfully, a restriction
digest with SacI was completed (Figure 3.21). It was expected the plasmid would be
unchanged if the fragment was removed successfully. This can be seen for plasmid 2.
In contrast, the original pMZ4 plasmid was linearised with the application of the SacI
restriction enzyme. This was further confirmed with sequencing (Appendix 5.9). The
final plasmid will be called ‘pMZ44BamHI’.
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Figure 3.21: Restriction digest (SacI) of isolated pMZ44BamHI
A restriction digest with SacI was completed on the isolated plasmid to ensure the
plasmid had successfully self-ligated. Also seen are undigested and digested versions
of the control plasmid, pMZ4.
3.6.4 Electroporation of pMZ44BamHI into Psa strains ICMP
18708 and M228
pMZ44BamHI was electroporated into M228 with an e ciency of 1.48x103 cfu/µg DNA
(Table 3.6). In comparison, the electroporation with ICMP 18708 yielded zero trans-
formants. Plasmids were isolated from M228 transformants (Figure 3.22). These
plasmids were subsequently sequenced (Appendix 5.10), revealing deletions of various
sizes and positions (Figure 3.23).
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Figure 3.22: Plasmid isolations from M228 transformants electroporated with
pMZ44BamHI plasmid
(a) pMZ44BamHI (A) (b) pMZ44BamHI (B)
Figure 3.23: Regions lost in the pMZ44BamHI plasmid isolated from M228
Using various primers, the Cas9 gene was sequenced. It revealed gaps missing from
plasmids isolated from M228. Specifically, positions 1,911 - 3263 bp and 2,370 -
4,367 bp were absent from Plasmids A and B, respectively. This is highlighted in red.
Figure created on Geneious 10.1.3 (Kearse et al., 2012).
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In conclusion, despite removal of M228 type I non-canonical restriction sites in the
pMZ44BamHI plasmid, a whole plasmid could not be isolated from M228 colonies.
It was also concluded that Cas9 toxicity was not the reason behind host lethality
given that the removal of the BamHI fragment did not yield in high transformations,
particularly for ICMP 18708. The BamHI fragment included the CRISPR array and
a portion of the Cas9 gene.
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3.7 Modification of the CRISPR/Cas9 plasmid -
GC content
After the removal of known restriction sites (canonical and non-canonical), isolation
of an intact plasmid from Psa was still elusive. Attention turned to the hypothesis
that the abnormal GC content of the CRISPR/Cas9 plasmid was causing cloning
problems in Psa but evidently not E. coli. It was observed that the Streptococcus pyo-
genes derived Cas9 encoding gene (2,419 - 6,525 bp) had a comparatively lower GC
content of 35.2% compared to the average 42.8% of the whole plasmid. Furthermore,
the sequence between the two NdeI restriction sites has an even lower GC composition
of 33.2%. Psa has an average GC content of 58%. The disparity in GC composition
between the Psa genome and CRISPR/Cas9 plasmid may be leading to plasmid in-
stability observed in Psa but not E. coli. This may be reflective of the disruption in
replication due to the high AT template or formation of secondary structures due to
the large number of A and T polymeric tracts.
To explore if the GC content was impacting on the plasmids’ ability to transform, a
newly synthesised sequence engineered to have a higher GC content was made, with
the same amino acid encoding sequence retained (Appendix 5.1). The synthetic frag-
ment spans between the two NdeI restriction sites (positioned at 2,897 bp and 4,332
bp of the pMZ4 plasmid), allowing for it to be cloned into pMZ4. This fragment was
chosen because the removal of it from pMZ4 yielded a higher transformation e ciency
(Figure 3.6). The synthetic version of the fragment has a higher GC composition of
48.3% compared to the original 33.2% (Figure 3.24). Furthermore, restriction sites
were introduced into the synthetic NdeI fragment that were not found in the original
fragment such as SalI. Similarly, several restriction sites found in the original frag-
ment were removed in the synthetic version such as EcoRI. This was to allow for the
di↵erentiation of the original fragment from the synthetic fragment when cloned into
the CRISPR/Cas9 plasmid.
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Figure 3.24: GC content of NdeI fragment
GC content of the original NdeI fragment compared to the GC content of the
synthetic NdeI fragment. Figure adapted from graphs generated by Geneious 10.1.3
(Kearse et al., 2012).
3.7.1 pUCP22+NdeI
Previously, di↵erent portions of the CRISPR/Cas9 plasmid were cloned into pUCP22
and transferred into Psa to identify regions of significance (Zhao, 2015). One of these
fragments were between 3,261 bp and 4,735 bp (fragment 2) of the pMZ2 plasmid
(Figure 1.4) which correspond to similar coordinates of the NdeI fragment that was
re-synthesised. The result of which was unfavourable with no transformants observed
(Zhao, 2015). Therefore, to compare and contrast, the modified NdeI fragment was
also cloned into pUCP22 and transformed into Psa to test its transferability and
stability. The synthetic fragment also contains XbaI and EcoRI sites external to
the NdeI restriction sites, allowing it to be cloned into the pUCP22 plasmid (Figure
3.25). As this fragment sits within the pUC57 Kan plasmid, a restriction digest was
completed with XbaI and EcoRI to separate the NdeI fragment from the plasmid.
Insertion of the NdeI fragment into corresponding XbaI and EcoRI sites of pUCP22
disrupted the ↵ peptide encoding sequence. White colonies were therefore selected.
Plasmids were isolated from four white colonies and subsequently interrogated with
a double restriction digest of XbaI and EcoRI. A band approximately 1.4 kb can
be observed for plasmid 3 and plasmid 4 indicating the synthetic NdeI fragment
had successfully incorporated into pUCP22. This was validated through sequencing
(Appendix 5.11). The resulting plasmid will be referred to as pUCP22+NdeI.
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Figure 3.25: Cloning new NdeI fragment into pUCP22 plasmid
The pUC57 plasmid carrying the newly synthesised NdeI fragment was digested with
XbaI and EcoRI. It was subsequently ligated into the corresponding insertion site of
pUCP22 plasmid. The ligation was transformed into E. coli DH5↵. Plasmid
isolations were completed from four white colonies. They were subjected to a double
restriction digest (EcoRI and XbaI), with the red arrow indicating the expected band
if cloning was successful.
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3.7.2 Electroporation of pUCP22+NdeI into Psa strains ICMP
18708 and M228
pUCP22+NdeI was electroporated into ICMP 18708 and M228 with an e ciency of
2.55x103 cfu/µg DNA and 1.64x107 cfu/µg DNA, respectively (Table 3.6). To analyse
this further, the plasmid was purified from the resulting colonies. When compared
against the stock pUCP22+NdeI, the plasmid isolations were of similar size suggesting
they were intact and did not su↵er any deletions (Figure 3.26). Sequencing data was
able to confirm this result (Appendix 5.12).
Figure 3.26: Plasmid isolations from ICMP 18708 and M228 transformants electro-
porated with pUCP22+NdeI plasmid
In summary, the modified version of this fragment with a more equal GC content
in pUCP22 was able to transform with a high e ciency. In comparison, previous
experiments with a similar fragment with an unrevised GC content, was unable to do
so (Figure 1.4) (Zhao, 2015). Furthermore, the resulting plasmids were stable.
3.7.3 pMZ4 to pMZ5 (replacement of NdeI fragment)
It was proven that the modified NdeI fragment residing in pUCP22 was able to transfer
as an intact plasmid into ICMP 18708 and M228. Following this result, it was desirable
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to replace the original fragment in pMZ4 with the modified version. This was achieved
by cutting out the original NdeI fragment in pMZ4 with the NdeI restriction enzyme
(Figure 3.27). Similarly, the synthetic NdeI fragment was cut out of pUCP22+NdeI.
The synthetic NdeI fragment was subsequently ligated into the cut pMZ4 vector. An
EcoRI site was present in the original NdeI fragment but absent from the modified
version. Therefore, EcoRI was also added to the restriction reaction to cleave the
original NdeI fragment to abolish its presence in the ligation.
The transformants were screened with a colony PCR using specific primers to the
Cas9 region; F2 and R2 3. PCR samples 2F and 2B were observed with a positive
band of 1,857 bp in length. The PCR products were purified and subjugated to SalI
restriction digest. This restriction site is present within the synthetic NdeI fragment
but absent inside the original piece. Two bands were expected at approximately
1,084 bp and 773 bp in length. This can be observed for both 2B and 2F. A third
band can also be seen and is likely to be undigested product. A plasmid isolation
was completed from corresponding colonies. The isolated plasmids were observed
to be the same size as pMZ4. Again, a restriction digest analysis was completed
with SalI. pMZ4 contains two SalI sites while the new modified plasmid harbours
three. Two extra bands can be seen at 3,863 bp and 4,155 bp in length compared to
pMZ4, further indicating the successful incorporation of the synthetic NdeI. Again,
undigested/partially digested plasmids can be seen for all samples. The insertion of
the synthetic NdeI was validated through sequencing (Appendix 5.13). The resulting
plasmid will be referred to as ‘pMZ5’. The modification has resulted in an increased
average GC content of 45.2% for pMZ5 compared to 42.8% for pMZ4.
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Figure 3.27: Cloning of the synthetic NdeI fragment into pMZ4 plasmid
The original NdeI fragment was removed from the pMZ4 plasmid with NdeI enzymes
and replaced with the synthetic fragment. EcoRI was used in conjunction to prevent
the fragment ligating back into the plasmid. The synthetic fragment was cut using
NdeI from pUCP22+NdeI. The ligation was transformed into E. coli DH5↵. A colony
PCR and subsequent restriction digest was completed. This indicated two colonies
had plasmids that successfully incorporated the synthetic fragment. The plasmids
were isolated from the corresponding colonies and again subjugated to a restriction
digest analysis. Both plasmid samples seemed to agree with the expected outcome.
The red arrows indicate the anticipated bands. Note, undigested or partially digested
product can also be observed.
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3.7.4 Electroporation of pMZ5 into Psa strains ICMP 18708
and M228
pMZ5 was introduced into the Psa strains ICMP 18708 and M228. The highest
e ciency of transformation observed was 3.75x102 cfu/µg DNA and 7.14x101 cfu/µg
DNA, respectively (Table 3.6). The first electroporation yielded four colonies in total
for both the transformations of ICMP 18708 and M228. A colony PCR was used to
confirm the presence of a 1.8 kb region of the Cas9 encoding gene (Figure 3.28a).
Only M228 colony two tested positive.
The electroporation was repeated. However, prior to plating, the electroporated cells
were spun down and re-suspended in a smaller volume of Luria broth to increase
the concentration of electroporated cells to double the original. This yielded more
colonies. The colonies were subcultured onto a separate plate in a grid formation.
The rows and columns were labelled A-G and 1-14, respectively. A colony PCR was
completed for each row and column. The colonies making up each row and column
were pooled together for their respective colony PCR. The results concluded M228
colony D14 tested positive for the 1.8 kb region of the Cas9 encoding gene (Figure
3.28b). Despite having a higher transformation e ciency, all ICMP 18708 colonies
tested were negative for this 1.8 kb region.
Plasmid isolations from colony 2 and colony D14 were completed (Figure 3.29). Plas-
mid D12 was observed to be comparable size to the control plasmid, pMZ5. However,
sequencing analysis of this plasmid revealed a gap approximately 800 bp in length
within plasmid D14 (Figure 3.30b).
Plasmid 2 also contained bands comparable in size to the control. However, other
bands were also observed, suggesting the plasmid preparation was either fragmented
or two plasmids were present. It was possible, the plasmid preparation from colony
2 was not from a pure culture. The presence of another plasmid variation was con-
firmed through sequencing where overlapping sequences were observed (Appendix
5.14). Analysis of this overlapping sequence revealed that one species of plasmid in
colony 2 had undergone recombination with the direct repeats found in the tracrRNA
and CRISPR array, thus, eliminating a majority of pMZ5. The other variation of
plasmid seen in colony 2 appeared to be more dominant, with stronger peaks corre-
sponding to this plasmid species. This plasmid variation appeared to only contain a
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very small gap of 93 bp in length (Figure 3.30a). Moreover, this gap was located be-
tween the tracrRNA and Cas9 encoding region. All components of the pMZ5 plasmid
were present in one of the plasmid variations from colony 2.
(a) Colony PCR of colonies
from first electroporation
(b) Colony PCR of colonies from second electroporation
Figure 3.28: Colony PCR of ICMP 18708 and M228 transformants
ICMP 18708 and M228 transformants were interrogated with primers specific to a
1.8 kb region of the Cas9 encoding gene.
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Figure 3.29: Plasmid isolations from M228 transformants electroporated with the
pMZ5 plasmid
(a) pMZ5 (2) (b) pMZ5 (D14)
Figure 3.30: Plasmid isolations from M228 transformants electroporated with the
pMZ5 plasmid
Using various primers, the Cas9 gene was sequenced. It revealed gaps missing from
plasmids isolated from M228. Specifically, positions 2,237 - 2,328 bp and 2,007 -
2,811 bp were absent from plasmids 2 and D14, respectively. This is highlighted in
red. Figure created on Geneious 10.1.3 (Kearse et al., 2012).
79
In summary, a number of alterations were made to the CRISPR/Cas9 plasmid. For
example, the removal of all known Psa RM sites was completed. However, none
of these changes completely overcame the incompatibility that plagued the trans-
formation of the pMZ plasmids into Psa. This led to the belief that the abnormal
GC composition of the S. pyogenes derived CRISPR components were impeding the
transfer and stability of the plasmid in Psa. By revising the GC content of the NdeI
fragment within the Cas9 encoding region, the gaps identified in the Psa plasmid iso-
lations were smaller than previous preparations from prior transformation attempts.
Moreover, the gaps did not include the revised portion of the CRISPR/Cas plasmid.
In fact, plasmid 2 isolated from M228 (Figure 3.30a) had all the components of the
CRISPR/Cas9 system still present.
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4. Discussion
CRISPR/Cas9 assisted gene editing represents a valuable tool in investigating specific
genes of interest in a variety of organisms including bacteria (reviewed in Doudna and
Charpentier, 2014). With the appearance of Psa in New Zealand causing extraordi-
nary losses to kiwifruit cultivars (Everett et al., 2011) it would be of benefit to suc-
cessfully develop CRISPR/Cas9 in Psa to target genes, or even whole plasmids/ICE
elements, suspected to contribute to its virulence. Moreover, with the widespread use
of antimicrobials, acquisition of copper and streptomycin resistance genes on mobile
elements has been observed in Psa (Kiwifruit Vine Health, 2015; Poulter et al., 2016;
Colombi et al., 2017). Again, CRISPR/Cas9 can be used to further explore the basis
of antimicrobial resistance in Psa. It may provide significant insight into the link
between genotype and phenotype.
Here, a number of strategies were employed in an e↵ort to introduce the CRISPR/Cas9
plasmid into Psa. As an overview, it was hypothesised that the RM systems found in
Psa were preventing successful plasmid transformation. Conjugative transfer of the
CRISPR/Cas9 plasmid and restriction alleviation were explored as a means to cir-
cumvent these hypothesised RM systems. A comparative genomic analysis of several
Psa strains was also completed to further investigate Psa RM systems. This RM anal-
ysis informed the alteration of the CRISPR/Cas plasmid to remove known restriction
sites. This resulted in several derivatives. After transformation experiments of such
plasmid derivatives into Psa, it was proposed the abnormal GC content of the Strepto-
coccus pyogenes derived CRISPR/Cas gene sequences was preventing transformation
of the plasmid.
Recently, the utilisation of CRISPR/Cas9 has been documented in P. putida (Aparicio
et al., 2017; Sun et al., 2018). Aparicio et al. was able to show that the system
could modulate single nucleotide substitutions and gene deletions (Aparicio et al.,
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2017). This was also achieved by Sun et al., however, they were also able to further
demonstrate gene insertion and gene replacement at a mutation e ciency of up to 70%
in P. putida (Sun et al., 2018). In both studies, the CRISPR array was placed on a
separate plasmid from the Cas9/tracrRNA elements. Moreover, the study introduced
the plasmid carrying the Cas9/tracrRNA elements into P. putida via conjugation.
The plasmid carrying the CRISPR array was subsequently transferred separately via
electroporation (Aparicio et al., 2017; Sun et al., 2018). Sun et al. initially trialled
electroporation as a means of transformation for the Cas9/tracrRNA plasmid but
observed zero to very low transformation e ciency which could not be explained (Sun
et al., 2018). Since similar results were also observed in the transformation of Psa,
it could be suggested the low e ciency observed in P. putida could be potentially
due to the RM systems of P. putida or the low GC content of the CRISPR/Cas9
elements which were also derived from S. pyogenes. The e↵ect of RM systems and
GC composition in respect to the CRISPR/Cas9 plasmid in Psa are discussed here
and may be applicable to P. putida.
4.1 E↵orts to escape Psa restriction modification
systems
Previous attempts to introduce the CRISPR/Cas9 plasmid into Psa, specifically that
of the early New Zealand isolate ICMP 18708, were unsuccessful (Zhao, 2015). It was
hypothesised that RM systems residing in Psa were the issue (Zhao, 2015). Therefore,
several methods were trialled in an attempt to avoid such RM systems.
4.1.1 Conjugation
A potential approach to circumvent the hypothesised RM systems of Psa was to
introduce the CRISPR/Cas9 plasmid (pMZ3) into Psa via conjugation rather than
the previously trialled method of electroporation. This approach was partly based on
the successful mobilisation of ICE elements between di↵erent Psa strains and other
Pseudomonas (Zhao et al., 2017; Colombi et al., 2017). These ⇠100 kb elements,
carrying recognised RM motifs, has been observed to self-excise from the core genome
and transfer through conjugation to other Psa (Zhao et al., 2017; Colombi et al., 2017).
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The elements’ successful mobilisation and integration suggests endogenous restriction
enzymes does not a↵ect all foreign ICE element DNA. Furthermore, introduction of
the plasmid carrying the Cas9 encoding gene and tracrRNA in P. putida was achieved
through conjugation (Aparicio et al., 2017; Sun et al., 2018). This led to the idea of
conjugative transfer being a potential method to avoid RM systems and in doing so
successfully introduce the CRISPR/Cas plasmid.
During the process of conjugation, the plasmid is nicked and enters the recipient cell as
a single-stranded intermediate (Gri ths, 2005). As a majority of restriction enzymes
recognise and cleave non-methylated double-stranded DNA, it is predicted that single-
stranded DNA is able to evade RM systems (Lacks & Springhorn, 1984; Majewski,
2001; Berndt et al., 2003; Roer et al., 2015). Although not completely immune to
RM systems, it was shown that the conjugative transfer of plasmids compared to
phage transduction occurred at an 100 fold higher e ciency (Lacks & Springhorn,
1984). Phages typically introduce DNA into bacteria as a double strand (Lacks &
Springhorn, 1984). Similarly, when DNA was introduced through electroporation as
a duplex molecule, it was heavily restricted (Lefrancois & Sicard, 1997). With this in
mind, an attempt was made to introduce pMZ3 into the New Zealand Psa strain ICMP
18708 through conjugative transfer. Experiments demonstrated that the pMZ3+oriT
and pUCP22+oriT plasmid could successfully transfer into to the recipient strain E.
coli DH5↵. Furthermore, pUCP22+oriT was also able to transfer into the recipient
strain Psa ICMP 18708, showing that Psa can successfully take part in a conjugative
mating with the donor strain E. coli S17-1. However, when it came time to transfer
pMZ3+oriT into Psa, no transconjugants were observed.
The failure of transfer could be due to the RM system’s ability to restrict DNA
surpassing the protective quality of conjugation. Although transformation e ciency
of conjugative transfer is greater than that of double-stranded DNA introduction,
RM systems remain a barrier. The conjugation of plasmid DNA carrying two type
I recognition sites of the recipient E. coli K-12 strain showed an 85% reduction in
plasmid uptake when compared to the conjugation of the same plasmid into a mutant
E. coli K-12 (Roer et al., 2015). This mutant E. coli K-12 strain had a disrupted
hsdR gene (Roer et al., 2015). It is suspected restriction occurs when the plasmid




Eliciting RA in Psa was also attempted to temporarily suppress the RM systems of
the bacteria, allowing for transformation of the CRISPR/Cas9 plasmid into Psa. This
phenomenon has been observed when E. coli K12 was exposed to nalidixic acid or
ultra-violet (UV) light before the infection of bacteriophage (Day, 1977; Thoms &
Wackernagel, 1984). This resulted in the increased survival of phage (Day, 1977). UV
exposure and nalidixic acid causes DNA damage to the cell whereby unmethylated
sites can be created in the host genome, leaving it at risk of attack from endogenous
RM systems (Thoms & Wackernagel, 1984). To prevent cleavage of self DNA, the
protease ClpXP is activated (Makovets et al.,1998; Makovets et al., 1999). Upon
the binding and translocation of the HsdR subunit to unmodified sites of the host
DNA, ClpXP will degrade the restriction endonuclease, thereby preventing cleavage
(Doronina & Murray, 2001; Simons et al., 2014). This mechanism has been displayed
for certain families of type I RM systems - type IA and type IB (Makovets et al.,
1998).
Nalidixic acid has been shown to induce RA in E. coli at a concentration of 10
µg/ml (Thoms & Wackernagel, 1984). However, pseudomonads present a consider-
ably stronger resistance to nalidixic acid, with 64 µg/ml needed to achieve a 50% min-
imum inhibitory concentration (MIC) in P. aeruginosa compared to 4 µg/ml needed
to reach a 50% MIC in E. coli (Van Caekenberghe & Pattyn, 1984). This amount of
nalidixic acid could alter the pH. Therefore, another quinolone, ciprofloxacin, was tri-
alled where a much lower concentration was needed (Figure 3.13) (Van Caekenberghe
& Pattyn, 1984). Like nalidixic acid, ciprofloxacin causes stalling of DNA replication
by inhibiting DNA gyrase (Sugino et al., 1977; Phillips et al., 1987; LeBel, 1988).
The application of ciprofloxacin prior to the electroporation of ICMP 18708 and M228
with the CRISPR/Cas9 plasmid did not yield in an increase of successful transfor-
mants (Table 3.5). Optimisation of the method may provide a more positive out-
come. Factors such as pH of growth media, incubation temperature, concentration of
ciprofloxacin and time of exposure to ciprofloxacin could be tested at di↵erent values
to identify if RA indeed occurs in Psa and thereafter optimise the procedure. For
example, the application of nalidixic acid to E. coli K12 yielded highest RA activity
at pH 7 of the growth medium (Thoms & Wackernagel, 1984). Unfortunately, time
did not permit optimisation. Once ciprofloxacin induced RA activity is confirmed, it
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could be further optimised.
4.2 Restriction modification systems in Psa
To characterise the repertoire of RM systems in Psa, a bioinformatic analysis was
undertaken. With the advent of PacBio sequencing, the detection of methylated
motifs across the sequenced genome and in turn the identification of associated RM
system has become more approachable. This, coupled with comparative genomics,
has allowed further detail of Psa RM systems. Templeton et al., was able to show
that a New Zealand Psa isolate contain two functional RM systems, a type I and type
II (Templeton et al., 2015). Here, RM systems in several Psa strains and its close
relative P.s pv. theae ICMP 3923 were compared and discussed.
It was apparent there had been gains and losses of RM systems in the various Psa
strains examined. The dynamic nature of RM systems had been investigated in He-
licobacter pylori with the use of comparative genomics (Lin et al., 2001). H. pylori
harbours an unusually high number of RM systems, likely a result of it being naturally
competent (Kong et al., 2000). The characterisation of type II RM complexes showed
a spectrum of RM systems present in the H. pylori genome, from being fully active
to non-functional genetic remnants (Lin et al., 2001). Lin et al, go on to describe
how approximately 90% of RM genes were shared between the two H. pylori strains
analysed. Despite this, a unique set of RM genes were functionally active in each
strain.
Like H. pylori, each Psa strain analysed had a unique set of RM systems predicted
to be active (Table 3.1). There were some overlap observed, specifically the type II
RM system recognising CTCGAG, which was found in both the NZ Psa strain and
P.s pv. theae. Conversely, there were examples where RM genes were not functional.
For example, it was evident the putative type II DNA methyltransferase/restriction
endonuclease (at ⇠1.1 Mb) had been disrupted with the addition of two MITES in
the NZ Psa genome. This was also observed in the Chinese Psa genome. Similarly,
the type III RM system (at ⇠1.8 Mb in the NZ genome) also contained two MITES
inserted within the ORF. On the other hand, the Chinese homologue was disrupted
with just one MITE. Another example of a disabled DNA methyltransferase was the
type I RM system (at ⇠33 kb) in the NZ genome, which has an IS element inserted
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within the methyltransferase gene (Figure 3.2). It was present in the ‘first acquisition’
shared with the Chinese Psa strain. However, the version present in the Chinese Psa is
not disrupted and is predicted to be functional. The corresponding PacBio sequencing
data show a type I recognition site di↵erent from that of the NZ strain. It is clear
with the multiple examples observed, that transposable elements are an important
factor in controlling the number of functional RM systems present within a genome.
The dynamic nature of RM systems may be motivated by the role of RM systems as
a defence system in bacteria. To provide adequate protection, the RM systems must
maintain an evolutionary advantage against foreign invaders such as bacteriophages
(Korona et al., 1993). Bacteriophages have evolved mechanisms to minimise the
presence of bacterial restriction target sites so as to avoid attack (Sharp, 1986; Gelfand
& Koonin, 1997). The addition of a novel RM system would provide the bacterium
a completely new target for defence, disabling incoming bacteriophages that could
previously withstand the former RM system repertoire.
RM systems have often been associated with horizontal gene transfers despite also
being a gene barrier (Jeltsch & Pingoud, 1996; Furuta & Kobayashi, 2013). Strain
specific RM systems present in H. pylori were suggested to be acquired through hor-
izontal gene transfer because of the di↵erent GC composition observed between the
RM genes and the H. pylori genome (Lin et al., 2001). It is predicted many RM
systems in Psa were acquired through horizontal gene transfer because genes adjacent
to the RM genes were often strain specific. Moreover, several of the flanking genes
were related to those found on conjugative elements or prophages. For example, the
Japanese genome harbours a strain specific type III RM system, Psy9853II (at ⇠6.0
Mb) with phage associated genes found adjacent to the RM encoding genes. Also
in the vicinity were transposons and integrases which might facilitate in the mobil-
ity of the RM system (Brassard et al., 1995; Kita et al., 2003). Counter-intuitively,
bacteriophages have been shown to provide a source of novel RM systems in other
bacteria, such as the introduction of a type II RM system into E. coli by the P4 phage
(Kita et al., 2003). Plasmids and ICE elements have also been shown to harbour RM
systems (Burrus et al., 2001; Naderer et al., 2002). It was predicted the type II RM
system found in the Japanese strain (at ⇠1.7 Mb) was of ICE element or plasmid
descent. Genes predicted to encode for chromosome partitioning proteins and P-type
conjugative transfer proteins were found in the vicinity of the type II RM genes.
As well as being a potential gain to the organism, the addition of a new RM system
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could come at a fitness cost too (Vasu & Nagaraja, 2013). The methylation of the
host genome required to protect from self-cleavage could potentially slow DNA repli-
cation and become energetically costly if there were many RM systems, hence, RM
systems may be lost. Discussed earlier were examples of transposable elements dis-
rupting RM genes. Another example of RM gene loss involves the type II RM system;
Psy18884II. The sequence surrounding Psy18884II that was present in the NZ strain
(at ⇠0.18 Mb) was also present within the Korean strain, however it was observed
genes encoding the RM system had been lost (Figure 3.3). In a more extreme man-
ner, Psy18884II along with the surrounding sequences is completely absent from the
Japanese genome (Figure 3.3). Considering the majority of this region was present
in other pseudomonads analysed, it was hypothesised this region was lost from the
Japanese strain.
As well as providing a defence mechanism against foreign invaders, the presence of
RM systems will consequently shape the evolution of the organism (Vasu & Nagaraja,
2013). RM systems act as a gatekeeper for incoming horizontal transfer events with
di↵erent recognition sites imposed from various Psa strains harbouring di↵erent RM
systems. RM systems may impact directly on the uptake of DNA that might provide
useful genetic material such as virulence and antimicrobial resistance (von Winters-
dor↵ et al., 2016). In the case of Psa, high-level copper and streptomycin resistance
have been established through the uptake of plasmids and ICE elements (Poulter et
al., 2016; Colombi et al., 2017; Zhao et al., 2017). Sequence analysis of these elements
(some of which are over 100 kb in length) show the presence of restriction sites recog-
nised by Psa RM systems. As discussed before, there are ways in which to circumvent
the RM system, such as conjugation or restriction alleviation. The bacterium has to
balance between preventing uptake of unwanted DNA and allowing DNA of potential
benefit to enter the cell.
4.3 Psa restriction sites in the CRISPR/Cas9 plas-
mid
Previous experiments led to the hypothesis that Psa RM systems pose a barrier against
the transformation of the CRISPR/Cas9 plasmid into Psa (Zhao, 2015, 2016). Here,
this notion was explored through the alteration of the plasmid to remove sites pre-
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dicted to be recognised by the restriction systems of Psa. The number of restriction
sites present in these plasmids and their relative transformation e ciencies into ICMP
18708 and M228 are summarised in Table 4.1. These experiments suggest that the
RM systems of Psa may have an e↵ect on plasmid tranformation to some degree.
Table 4.1: Number of Psa RM sites present within di↵erent plasmids and the trans-
formation e ciency of these plasmids into ICMP 18078 and M228
pUCP221 pMZ3 pMZ4
# of TE2 # of TE2 # of TE2
sites (cfu/µg DNA) sites (cfu/µg DNA) sites (cfu/µg DNA)
M228 0 3.39x107 0 5.41x102 0 9.35x101
ICMP 18708 2 1.76x105 1 0 0 6.39x102
1Control
2Transformation e ciency
Prior experiments completed used the NZ Psa strain ICMP 18708 as the electropo-
ration recipient (Zhao, 2015). However, after characterisation of RM systems in an
array of Psa strains, the Chinese strain M228 was perceived as a more appropriate
recipient of the CRISPR/Cas9 plasmid. PacBio sequencing methylome data suggest
only one type I RM system is active (Table 3.1). Importantly, this M228 restriction
enzyme does not recognise any sites in the pMZ3 or pUCP22 plasmid (Table 3.3). In
comparison, ICMP 18708 recognises a type I restriction site (AGCAN5GTC), which
is present in the ampicillin resistance gene of pMZ3.
When pMZ3 was electroporated into M228, a transformation e ciency of 5.41x102
cfu/µg DNA was observed compared to zero transformants seen with the introduction
of same plasmid into ICMP 18708 (Table 3.6). The zero transformants observed in
ICMP 18708 may be partly due to the recognition of the type I restriction site present
in the ampicillin resistance gene.
The ampicillin resistance gene is a component present in both pMZ3 and the control
plasmid, pUCP22. Furthermore, another restriction site was also identified in the
gentamicin resistance gene in pUCP22. Despite the presence of two restriction sites
in pUCP22, the plasmid could still be transferred with an e ciency of 1.76x105 cfu/µg
DNA into ICMP 18708 (Table 3.6). In contrast, transformation of pUCP22 into M228
88
was more e cient with an e ciency of 3.39x107 cfu/µg DNA (Table 3.6). With no
restriction enzymes recognising pUCP22 in M228, transformation was predicted to
not be limited. Meanwhile, with the presence of two ICMP 18708 restriction sites in
pUCP22, it is predicted to have caused reduced transfer rates in ICMP 18708.
At an attempt to clarify the e↵ect of the ICMP 18708 type I restriction site, the ampi-
cillin resistance gene in pMZ3 was removed and replaced with a kanamycin resistance
gene, giving the resulting plasmid pMZ4 (Figure 3.14). This gene contains no known
restriction sites of either ICMP 18708 or M228. When this plasmid was electropo-
rated into ICMP 18708 and M228 an e ciency of 6.39x102 cfu/µg DNA and 9.35x101
cfu/µg DNA were observed, respectively (Table 3.6). The increased number of ICMP
18708 colonies with the transformation of pMZ4 compared to the transformation of
pMZ3 suggests the type I restriction site found in the ampicillin resistance gene was
having some e↵ect on its transfer rate.
Taken together, it is hypothesised that known RM systems of Psa exert some e↵ect
on the transformation e ciency of the CRISPR/Cas9 plasmid. However, experiments
also clearly show that other factors are a↵ecting transformation and plasmid stability.
Plasmid isolations completed from ICMP 18708 and M228 transformants of both
plasmid derivatives (pMZ3 and pMZ4) had deletions. It was hypothesised these results
may be due to known RM systems of Psa recognising non-canonical restriction sites
present in the plasmid.
4.4 Non-canonical restriction sites in the CRISPR/
Cas9 plasmid
The possibility of known RM systems in ICMP 18708 and M228 recognising non-
canonical restriction sites were considered. Restriction enzymes were previously thought
to have a high specificity to their recognition sites, however, numerous examples have
shown this may not be the case (Saravanan et al., 2007; Wei et al., 2008). For example,
type II restriction enzyme KpnI exhibits promiscuous DNA cleavage with the pres-
ence of excess Mg2+ (Saravanan et al., 2007). Other type II restriction enzymes with
relaxed recognition specificity can be quantified with the Fidelity Index and often dis-
play cleavage promiscuity at certain environments e.g. di↵erent pH (Wei et al., 2008).
In terms of type I RM systems, there has been work to show genetic rearrangements
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can cause changes in the bipartite recognition sequence (Colson & Van Pel, 1974;
Fuller-Pace et al., 1984). This was first observed in Salmonella where components
from di↵erent type I hsdS, conferring specificity to one part of the bipartite sequence,
recombine to form a novel version (Colson & Van Pel, 1974; Fuller-Pace et al., 1984).
In the case of the CRISPR/Cas9 plasmid, single base mismatches of type I restric-
tion sites were explored. Specific mismatches grouped within the problematic Cas9
encoding gene for both ICMP 18708 and M228 type I recognition sites.
The majority of such sites from ICMP 18708 were removed from the pMZ4 plasmid
with a digest using the NdeI restriction enzyme followed by re-ligation (Figure 3.20).
The resulting plasmid, pMZ44Ndel, was electroporated into ICMP 18708 and M228
with an e ciency of 1.30x105 cfu/µg DNA and 7.09x103 cfu/µg DNA, respectively
(Table 3.6). Sequencing of plasmid isolations from M228 and ICMP 18708 transfor-
mants revealed identical deletions. The regions flanking this gap were direct repeats
found within the CRISPR array and tracrRNA. It was likely that homologous recom-
bination between the repeats occurred, hence, the same gap was observed in multiple
plasmid preparations. Homologous recombination has been shown to occur with the
use of a dual RNA system encoded on the same plasmid (Jiang et al., 2013). In future
experiments this can be circumvented with the fusion of the crRNA and tracrRNA
into one gene product (Jiang et al., 2013).
The removal of a 1.4 kb region using Ndel yielded an increase of transformation
e ciency in both ICMP 18708 and M228. However, removal of this fragment would
completely disrupt the function of the CRISPR/Cas9 system. It was possible that
either the Cas9 endonuclease or the crRNA sequence specificity were impeding the
ability of the plasmid to transformation and remain intact. To investigate this, the
BamHI restriction enzyme was employed to remove a di↵erent 1.3 kb region of the
pMZ4 plasmid. This included the removal of the CRISPR array and part of the Cas9
endonuclease gene.
When the resulting plasmid, pMZ44BamHI, was transferred into M228, a transforma-
tion e ciency of 1.48x103 cfu/µg DNA was observed (Table 3.6). Conversely, zero
transformants were seen for the electroporation of ICMP 18708. This data indicates
the CRISPR/Cas9 system itself was not the barrier to its transfer into Psa. It also
showed that non-canonical restriction sites were also probably not the reason be-
hind the observed outcome. pMZ44BamHI does not have the identified non-canonical
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restriction sites of M228. If non-canonical sites were the issue, it was expected plas-
mid isolations of pMZ44BamHI from M228 would be intact. However, gaps varying
in size and position were observed (Figure 3.23). Therefore, we can also discount
non-canonical restriction sites as the reason for failure of transfer.
In summary, the removal of the NdeI-NdeI fragment from the pMZ4 plasmid yielded
a high e ciency of transformation in both Psa strains. However, there was a lack
of transformants when the BamHI-BamHI fragment was removed from pMZ4 and
transformed into ICMP 18708. These results suggest that it was likely non-canonical
recognition sites did not lead to low e ciency of plasmid transformation and insta-
bility in Psa. It also suggests that the CRISPR/Cas9 system was not causing host
lethality. This result was consistent with other analyses of the potential role of Cas9
toxicity (Sun et al., 2018). Constructions of the plasmid with di↵erent point muta-
tions and frame-shifts in the Cas9 encoding gene were engineered (Sun et al., 2018).
The electroporation of these modified plasmids into P. putida still resulted in low
transformation e ciencies, thus, eliminating Cas9 toxicity as the issue (Sun et al.,
2018).
Despite failing to isolate an intact CRISPR/Cas9 plasmid from Psa, the alterations
made to the CRISPR/Cas9 plasmid led to the suspicion that the NdeI-NdeI region
was preventing successful transformation of the CRISPR/Cas9 plasmid. This was
demonstrated by the higher e ciency observed in both ICMP 18708 and M228 when
the fragment was removed. Furthermore, this region (either completely or partially)
was often missing from CRISPR/Cas9 plasmid preparations from Psa. This was in
line with previous experiments where a similar section to the NdeI fragment was
cloned into pUCP22 (fragment 2; see Figure 1.4) (Zhao, 2015). The addition of this
region in pUCP22 prevented uptake into ICMP 18708 (Zhao, 2015). Taken together,
these experiments are indicative of the NdeI region as the reason of failure.
4.5 GC composition of the CRISPR/Cas9 elements
Removal of the NdeI-NdeI region in the pMZ4 reduced the amount of Steptococcus
pyogenes derived sequence in the pMZ4 plasmid. This may be the critical factor in
the issues that have arisen during transformation of the CRISPR/Cas9 plasmid into
Psa. It was noted that the Cas9 encoding region has a considerably lower GC content
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of 35.2% compared to the average of 42.8% seen in the whole pMZ4 plasmid. The
Ndel region itself is even lower with a GC content of 33.2%. The CRISPR elements
are derived from the pCas9 plasmid developed by Jiang et al. with it originating
from S. pyogenes (Jiang et al., 2013). Taking into consideration the GC composition
of the Pseudomonas strains analysed is approximately 58%, one hypothesis involves
the AT-rich region of the CRISPR/Cas9 plasmid preventing uptake. Cloning of AT-
rich DNA sequences in E. coli has been shown to be di cult such as those from
Dictyostelium discoideum with an GC content as low as 20% (Glöckner et al., 2002;
Godiska et al., 2009). Similarly, the human parasite Plasmodium falciparum has
an average GC composition of approximately 19.4% and is notoriously hard to clone
traditionally (Gardner et al., 2002). This instability seen in E. coli may be exacerbated
in Pseudomonas which has a higher average GC content compared to E. coli of 50.8%.
It is possible that undesirable secondary structures are forming in the AT-rich regions
of the CRISPR/Cas9 plasmid or replication has been distorted, leading to instability
and partial plasmid deletions in Psa.
To explore whether the AT-rich sequence of the Cas9 encoding gene was preventing
uptake of the whole plasmid in Psa, a newly synthesised DNA sequence was engineered
to have a higher GC content. Specifically, the newly synthesised DNA fragment was
between the two NdeI restriction sites and has a revised GC composition of 48.3%.
The synthetic NdeI fragment was firstly inserted into pUCP22 (giving a resulting plas-
mid called pUCP22+NdeI) (Figure 3.25). This plasmid was successfully transferred via
electroporation into ICMP 18078 and M228 at a transformation e ciency of 2.55x103
cfu/µg DNA and 1.64x107 cfu/µg, respectively (Table 3.6). Not only was transfor-
mation e ciencies at a relatively high level, but isolated plasmids were intact (Figure
3.26). Previous experiments showed that when a similar fragment of the original Cas9
encoding region (fragment 2; see Figure 1.4) was cloned into pUCP22, colonies could
not be recovered following the electroporation of Psa (Zhao, 2015). Comparison of
these two results implies the lower GC composition of the original NdeI fragment
prevented the pUCP22 plasmid from successfully transforming into Psa.
Following from this experiment, pMZ4 was modified to have the synthetic NdeI frag-
ment replace the original fragment (Figure 3.27). This formed the new plasmid called
pMZ5. pMZ5 was electroporated into ICMP 18708 and M228 at a transformation ef-
ficiency of 3.75x102 cfu/µg DNA and 7.14x101 cfu/µg DNA, respectively (Figure 3.6).
Through colony PCR two M228 colonies; colony 2 and colony D14 tested positive for a
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1.8 kb region within the Cas9 encoding gene. Unfortunately, all ICMP 18708 colonies
tested were negative. When the corresponding plasmids from M228 were isolated
and sequenced, gaps were still identified (Figure 3.30). However, these deletions were
much smaller than those identified from previous plasmid preparations from Psa. In
fact, plasmid 2 contained a mere 93 bp deletion, found between the tracrRNA region
and Cas9 encoding gene. The deletion appears to have not disrupted any components
of the CRISPR/Cas9 system. Plasmid D12 contains a deletion approximately 800 bp
long. Interestingly, this gap does not include the modified NdeI fragment. This is
the first time that sequences equivalent to fragment 2 residing within a pMZ plasmid
(Figure 1.4) have been electroporated into Psa.
The isolation of a plasmid from Psa with all CRISPR/Cas components present was a
major step forward in the utilisation of the genome-editing tool in Psa. This demon-
strated the transformation of the CRISPR/Cas9 plasmid into Psa is possible. It also
highlighted the importance of GC composition as the primary limitation.
4.6 Future perspectives
By using PacBio sequencing, the identification of RM systems in several Psa strains
was achieved. Methylation motifs were also analysed in P.s pv. theae ICMP 3923, a
close relative of Psa. Experimental work could be completed to further analyse and
confirm RM system activity, particularly, restriction endonuclease functionality.
In terms of the CRISPR/Cas9 system, the isolation of a plasmid including all the
CRISPR/Cas9 components was very encouraging for further CRISPR/Cas9 studies
in Psa. It demonstrated that the GC composition of the plasmid in relation to the
recipient host genome was very important. In an e↵ort to further improve the trans-
formation e ciency and stabilise the CRISPR/Cas9 plasmid, other regions of the
CRISPR/Cas structure could be modified to have a higher GC content reflective of
the Psa genome. Of specific interest would be the beginning of the Cas9 gene and
the region surrounding the tracrRNA region. This particular region was lost from
plasmid D12 which was isolated from M228 (Figure 3.30b), suggesting this fragment
was unstable in Psa.
The CRISPR/Cas9 system in P. putida has been separated into di↵erent plasmids
with the Cas9/tracrRNA on one plasmid and the CRISPR array on another (Aparicio
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et al., 2017; Sun et al., 2018). Separating the elements could be investigated in the
system’s application in Psa. One approach would be to select a Psa strain carry-
ing the CRISPR/Cas9 system. Presently, a kanR M228 strain has been shown to
carry all components of the CRISPR/Cas9 system on a transformed plasmid (plasmid
2) (Figure 3.30a). This strain will be designated as M228+pMZ5. M228+pMZ5 could
be transformed with a second smaller plasmid, for example pUCP22, carrying the
CRISPR array. This approach would allow for easier modification and introduction
of the crRNA/gRNA.
Conjugation was also the preferred method of introducing the Cas9/tracrRNA plasmid
into P. putida (Aparicio et al., 2017; Sun et al., 2018). Conjugation of pMZ5 into Psa
would be valuable to explore and may be more successful than the conjugation of its
predecessor, the pMZ3 plasmid.
M228+pMZ5 could also be utilised to test CRISPR/Cas9 system functionality and
specificity. It is important to ensure CRISPR/Cas elements are able to express their
respective gene products and proteins and ensure functionality in Psa.
Once the CRISPR/Cas9 plasmid is stably introduced into Psa and functionality of
the system is confirmed, CRISPR/Cas9 can be harnessed to target genes related to
virulence and antimicrobial resistance in Psa. The majority of CRISPR/Cas9 genome
editing studies in bacteria have relied on HDR to repair CRISPR generated DSBs.
Many bacterial CRISPR/Cas9 studies have also required the addition of other repair
systems such as  -Red due to low e ciency of repair with the endogenous repair
system. NHEJ in bacteria should also be considered in CRISPR/Cas9 studies in bac-
teria. As determined in the introduction, many pseudomonads have a Ku/Lig gene
pair required for NHEJ machinery. During this analysis the presence of the Ku/Lig
gene pair was noted in various Psa biovars and other pseudomonads. Moreover, the
deletions observed in many of the plasmid preparations from Psa are indicative of a
NHEJ mechanism. The potential of Psa to perform NHEJ in addition to homologous
recombination could widen the utility of CRISPR/Cas9 in Psa and other pseudomon-
ads.
This low e ciency of DSB repair may also be useful in investigating whole plas-
mids and/or ICE elements. For example, strains from the Psa pandemic Biovar 3
lineage carry a unique 74 kb plasmid predicted to contribute to virulence. If the
CRISPR/Cas9 system can be successfully developed in Psa, Cas9 can be programmed
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to target the plasmid. Due to the low repair e ciency of DSBs, the entire plasmid
would likely be lost. Likewise, this can be applied to ICE elements residing in various
Psa strains. For instance, Pac ICE1 from the New Zealand Psa strains was shown
to excise from the genome and form a circular molecule (Butler et al., 2013). This
suggests that some ICE elements could remain as a separate DNA molecule after ex-
cision from the host genome. This particular state would allow the CRISPR/Cas9
system to specifically target the ICE element without causing lethality to the host.
By analysing the resulting bacteria, a greater understanding of Psa virulence and de-
velopment of resistance could be achieved. Findings of the genetic basis of virulence
and heavy metal/antibiotic resistance in Psa would be highly valuable due to the role
of Psa as an important plant pathogen in New Zealand and abroad.
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5. Appendix
Figure 5.1: Muscle alignment of original NdeI fragment and new synthetic NdeI
fragment
The sequence between the two NdeI restriction sites of the pMZ4 was altered to have
a higher GC content. The re-synthesised NdeI sequence is compared to the original
fragment. Note, the amino acid sequence remains unmodified. Figure created on
Geneious 10.1.3 (Kearse et al., 2012).
The following data is found on the CD-ROM.
5.2 Sequencing of pMZ3+oriT plasmid isolated from E. coli S17-1
5.3 Sequencing of pMZ3+oriT plasmid isolated from E. coli DH5↵ transconjugant
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5.4 Sequencing of pMZ3 plasmid isolated from Psa M228
5.5 Sequencing of pMZ4 plasmid
5.6 Sequencing of pMZ4 plasmid isolated from Psa ICMP 18708 and M228
5.7 Sequencing of pMZ44Ndel plasmid
5.8 Sequencing of pMZ44Ndel plasmid isolated from Psa ICMP 18708 and M228
5.9 Sequencing of pMZ44BamHI plasmid
5.10 Sequencing of pMZ44BamHI plasmid isolated from Psa M228
5.11 Sequencing of pUCP22+NdeI plasmid
5.12 Sequencing of pUCP22+NdeI plasmid isolated from Psa ICMP 18708 and M228
5.13 Sequencing of pMZ5 plasmid
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